| | UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| | OMB Number: 3235-0582 |
| | Expires: May 31, 2021 |
| | Estimated average burden |
| | hours per response........7.2 |
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 06565
Tekla World Healthcare Fund
(Exact name of registrant as specified in charter)
| 100 Federal Street, 19th Floor, Boston, MA | | 02110 |
| (Address of principal executive offices) | | (Zip code) |
Laura Woodward
Tekla World Healthcare Fund
100 Federal Street, 19th Floor, Boston MA 02110
(Name and address of agent for service)
Registrant’s telephone number, including area code: 617-772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/20-6/30/21
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
Vote Summary
1LIFE HEALTHCARE, INC.
| Security | 68269G107 | Meeting Type | Annual |
| Ticker Symbol | ONEM | Meeting Date | 03-Jun-2021 |
| Record Date | 05-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Bruce W. Dunlevie | | | | For | | For | |
| | | 2 | David P. Kennedy | | | | For | | For | |
| 2. | | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021. | | Management | | For | | For | |
ABBOTT LABORATORIES
| Security | 002824100 | Meeting Type | Annual |
| Ticker Symbol | ABT | Meeting Date | 23-Apr-2021 |
| Record Date | 24-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | R.J. Alpern | | | | For | | For | |
| | | 2 | R.S. Austin | | | | For | | For | |
| | | 3 | S.E. Blount | | | | For | | For | |
| | | 4 | R.B. Ford | | | | For | | For | |
| | | 5 | M.A. Kumbier | | | | For | | For | |
| | | 6 | D.W. McDew | | | | For | | For | |
| | | 7 | N. McKinstry | | | | For | | For | |
| | | 8 | W.A. Osborn | | | | For | | For | |
| | | 9 | M.F. Roman | | | | For | | For | |
| | | 10 | D.J. Starks | | | | For | | For | |
| | | 11 | J.G. Stratton | | | | For | | For | |
| | | 12 | G.F. Tilton | | | | For | | For | |
| | | 13 | M.D. White | | | | For | | For | |
| 2. | | Ratification of Ernst & Young LLP as Auditors. | | Management | | For | | For | |
| 3. | | Say on Pay - An Advisory Vote to Approve Executive Compensation. | | Management | | For | | For | |
| 4A. | | Amendments to the Articles of Incorporation to Eliminate Statutory Supermajority Voting Standards for: Amendments to the Articles of Incorporation. | | Management | | For | | For | |
| 4B. | | Amendments to the Articles of Incorporation to Eliminate Statutory Supermajority Voting Standards for: Approval of Certain Extraordinary Transactions. | | Management | | For | | For | |
| 5. | | Shareholder Proposal - Lobbying Disclosure. | | Shareholder | | Against | | For | |
| 6. | | Shareholder Proposal - Report on Racial Justice. | | Shareholder | | Against | | For | |
| 7. | | Shareholder Proposal - Independent Board Chairman. | | Shareholder | | Against | | For | |
ABBVIE INC.
| Security | 00287Y109 | Meeting Type | Annual |
| Ticker Symbol | ABBV | Meeting Date | 07-May-2021 |
| Record Date | 08-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Roxanne S. Austin | | | | For | | For | |
| | | 2 | Richard A. Gonzalez | | | | For | | For | |
| | | 3 | Rebecca B. Roberts | | | | For | | For | |
| | | 4 | Glenn F. Tilton | | | | For | | For | |
| 2. | | Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2021. | | Management | | For | | For | |
| 3. | | Say on Pay-An advisory vote on the approval of executive compensation. | | Management | | For | | For | |
| 4. | | Approval of the Amended and Restated 2013 Incentive Stock Program. | | Management | | For | | For | |
| 5. | | Approval of the Amended and Restated 2013 Employee Stock Purchase Plan for non-U.S. employees. | | Management | | For | | For | |
| 6. | | Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting. | | Management | | For | | For | |
| 7. | | Stockholder Proposal - to Issue an Annual Report on Lobbying. | | Shareholder | | Against | | For | |
| 8. | | Stockholder Proposal - to Adopt a Policy to Require Independent Chairman. | | Shareholder | | For | | Against | |
ABIOMED, INC.
| Security | 003654100 | Meeting Type | Annual |
| Ticker Symbol | ABMD | Meeting Date | 12-Aug-2020 |
| Record Date | 15-Jun-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Dorothy E. Puhy | | | | For | | For | |
| | | 2 | Paul G. Thomas | | | | For | | For | |
| | | 3 | C.D. Van Gorder | | | | For | | For | |
| 2. | | Approval, by non-binding advisory vote, of the compensation of our named executive officers. | | Management | | For | | For | |
| 3. | | Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2021. | | Management | | For | | For | |
AFFIMED N.V
| Security | N01045108 | Meeting Type | Annual |
| Ticker Symbol | AFMD | Meeting Date | 15-Jun-2021 |
| Record Date | 18-May-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 3. | | Adoption of the Statutory Annual Accounts for the financial year 2020. | | Management | | For | | For | |
| 4. | | Discharge of the managing directors for their management during the financial year 2020. | | Management | | For | | For | |
| 5. | | Discharge of the supervisory directors for their supervision during the financial year 2020. | | Management | | For | | For | |
| 6. | | Appointment of Ms. Denise Mueller to the Management Board. | | Management | | For | | For | |
| 7A. | | Reappointment of Dr. Ulrich Grau as a supervisory director. | | Management | | For | | For | |
| 7B. | | Reappointment of Dr. Mathieu Simon as a supervisory director. | | Management | | For | | For | |
| 7C. | | Appointment of Mrs. Uta Kemmerich-Keil as a supervisory director. | | Management | | For | | For | |
| 8. | | Appointment of the auditor for the financial year 2021. | | Management | | For | | For | |
| 9. | | Authorization to acquire shares. | | Management | | For | | For | |
AGILENT TECHNOLOGIES, INC.
| Security | 00846U101 | Meeting Type | Annual |
| Ticker Symbol | A | Meeting Date | 17-Mar-2021 |
| Record Date | 19-Jan-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Election of Director: Mala Anand | | Management | | For | | For | |
| 1.2 | | Election of Director: Koh Boon Hwee | | Management | | For | | For | |
| 1.3 | | Election of Director: Michael R. McMullen | | Management | | For | | For | |
| 1.4 | | Election of Director: Daniel K. Podolsky, M.D. | | Management | | For | | For | |
| 2. | | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | | Management | | For | | For | |
| 3. | | To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. | | Management | | For | | For | |
ALEXION PHARMACEUTICALS, INC.
| Security | 015351109 | Meeting Type | Special |
| Ticker Symbol | ALXN | Meeting Date | 11-May-2021 |
| Record Date | 30-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | To adopt the Agreement and Plan of Merger, dated as of December 12, 2020 (as it may be amended from time to time, the "merger agreement") by and among Alexion, AstraZeneca PLC ("AstraZeneca"), Delta Omega Sub Holdings Inc., a wholly owned subsidiary of AstraZeneca ("Bidco"), Delta Omega Sub Holdings Inc. 1, a direct, wholly owned subsidiary of Bidco and Delta Omega Sub Holdings LLC 2, a direct, wholly owned subsidiary of Bidco (the "merger proposal"). | | Management | | For | | For | |
| 2. | | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Alexion's named executive officers that is based on or otherwise relates to the transactions contemplated by the merger agreement. | | Management | | For | | For | |
| 3. | | To approve the adjournment of the Alexion special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Alexion special meeting to approve the merger proposal or to ensure that any supplement or amendment to this proxy statement/ prospectus is timely provided to Alexion stockholders. | | Management | | For | | For | |
ALIGN TECHNOLOGY, INC.
| Security | 016255101 | Meeting Type | Annual |
| Ticker Symbol | ALGN | Meeting Date | 19-May-2021 |
| Record Date | 24-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Kevin J. Dallas | | Management | | For | | For | |
| 1B. | | Election of Director: Joseph M. Hogan | | Management | | For | | For | |
| 1C. | | Election of Director: Joseph Lacob | | Management | | For | | For | |
| 1D. | | Election of Director: C. Raymond Larkin, Jr. | | Management | | For | | For | |
| 1E. | | Election of Director: George J. Morrow | | Management | | For | | For | |
| 1F. | | Election of Director: Anne M. Myong | | Management | | For | | For | |
| 1G. | | Election of Director: Andrea L. Saia | | Management | | For | | For | |
| 1H. | | Election of Director: Greg J. Santora | | Management | | For | | For | |
| 1I. | | Election of Director: Susan E. Siegel | | Management | | For | | For | |
| 1J. | | Election of Director: Warren S. Thaler | | Management | | For | | For | |
| 2. | | RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | BYLAW AMENDMENT: Ratify an Amendment of our Bylaws to designate Delaware and the District Courts of the United States as the Exclusive Forums for adjudication of certain disputes. | | Management | | For | | For | |
| 4. | | APPROVAL OF AMENDED STOCK PLAN: Approve the Amendment and Restatement of our 2010 Employee Stock Purchase Plan. | | Management | | For | | For | |
| 5. | | ADVISORY VOTE ON NAMED EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. | | Management | | For | | For | |
AMGEN INC.
| Security | 031162100 | Meeting Type | Annual |
| Ticker Symbol | AMGN | Meeting Date | 18-May-2021 |
| Record Date | 19-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. Wanda M. Austin | | Management | | For | | For | |
| 1B. | | Election of Director for a term of office expiring at the 2022 annual meeting: Mr. Robert A. Bradway | | Management | | For | | For | |
| 1C. | | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. Brian J. Druker | | Management | | For | | For | |
| 1D. | | Election of Director for a term of office expiring at the 2022 annual meeting: Mr. Robert A. Eckert | | Management | | For | | For | |
| 1E. | | Election of Director for a term of office expiring at the 2022 annual meeting: Mr. Greg C. Garland | | Management | | For | | For | |
| 1F. | | Election of Director for a term of office expiring at the 2022 annual meeting: Mr. Charles M. Holley, Jr. | | Management | | For | | For | |
| 1G. | | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. Tyler Jacks | | Management | | For | | For | |
| 1H. | | Election of Director for a term of office expiring at the 2022 annual meeting: Ms. Ellen J. Kullman | | Management | | For | | For | |
| 1I. | | Election of Director for a term of office expiring at the 2022 annual meeting: Ms. Amy E. Miles | | Management | | For | | For | |
| 1J. | | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. Ronald D. Sugar | | Management | | For | | For | |
| 1K. | | Election of Director for a term of office expiring at the 2022 annual meeting: Dr. R. Sanders Williams | | Management | | For | | For | |
| 2. | | Advisory vote to approve our executive compensation. | | Management | | For | | For | |
| 3. | | To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
ANTHEM, INC.
| Security | 036752103 | Meeting Type | Annual |
| Ticker Symbol | ANTM | Meeting Date | 26-May-2021 |
| Record Date | 22-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Election of Director: Lewis Hay, III | | Management | | For | | For | |
| 1.2 | | Election of Director: Antonio F. Neri | | Management | | For | | For | |
| 1.3 | | Election of Director: Ramiro G. Peru | | Management | | For | | For | |
| 2. | | Advisory vote to approve the compensation of our named executive officers. | | Management | | For | | For | |
| 3. | | To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2021. | | Management | | For | | For | |
ARDELYX, INC.
| Security | 039697107 | Meeting Type | Annual |
| Ticker Symbol | ARDX | Meeting Date | 16-Jun-2021 |
| Record Date | 20-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | William Bertrand Jr Esq | | | | For | | For | |
| | | 2 | Onaiza Cadoret-Manier | | | | For | | For | |
| | | 3 | Jan Lundberg, Ph.D. | | | | For | | For | |
| 2. | | To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on- Pay"). | | Management | | For | | For | |
ARGENX SE
| Security | 04016X101 | Meeting Type | Annual |
| Ticker Symbol | ARGX | Meeting Date | 11-May-2021 |
| Record Date | 13-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 3. | | Adoption of the new remuneration policy. | | Management | | For | | | |
| 4. | | Advisory vote to approve the 2020 remuneration report. | | Management | | For | | | |
| 5B. | | Adoption of the 2020 annual accounts. | | Management | | For | | | |
| 5D. | | Allocation of losses of the Company in the financial year 2020 to the retained earnings of the Company. | | Management | | For | | | |
| 5E. | | Proposal to release the members of the board of directors from liability for their respective duties carried out in the financial year 2020. | | Management | | For | | | |
| 6. | | Appointment of Yvonne Greenstreet as non-executive director to the board of directors of the Company. | | Management | | For | | | |
| 7. | | Re-appointment of Anthony Rosenberg as non-executive director to the board of directors of the Company. | | Management | | For | | | |
| 8. | | Authorization of the board of directors to issue shares and grant rights to subscribe for shares in the share capital of the Company up to a maximum of 10% of the outstanding capital at the date of the general meeting, for a period of 18 months from the annual general meeting and to limit or exclude statutory pre-emptive rights, if any. | | Management | | For | | | |
| 9. | | Appointment of Deloitte Accountants B.V. as statutory auditor for the 2021 financial year. | | Management | | For | | | |
ASTELLAS PHARMA INC.
| Security | J03393105 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 18-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1.1 | | Appoint a Director who is not Audit and Supervisory Committee Member Hatanaka, Yoshihiko | | Management | | For | | For | |
| 1.2 | | Appoint a Director who is not Audit and Supervisory Committee Member Yasukawa, Kenji | | Management | | For | | For | |
| 1.3 | | Appoint a Director who is not Audit and Supervisory Committee Member Okamura, Naoki | | Management | | For | | For | |
| 1.4 | | Appoint a Director who is not Audit and Supervisory Committee Member Sekiyama, Mamoru | | Management | | For | | For | |
| 1.5 | | Appoint a Director who is not Audit and Supervisory Committee Member Kawabe, Hiroshi | | Management | | For | | For | |
| 1.6 | | Appoint a Director who is not Audit and Supervisory Committee Member Ishizuka, Tatsuro | | Management | | For | | For | |
| 1.7 | | Appoint a Director who is not Audit and Supervisory Committee Member Tanaka, Takashi | | Management | | For | | For | |
| 2 | | Appoint a Director who is Audit and Supervisory Committee Member Shibumura, Haruko | | Management | | For | | For | |
ASTRAZENECA PLC
| Security | 046353108 | Meeting Type | Annual |
| Ticker Symbol | AZN | Meeting Date | 11-May-2021 |
| Record Date | 19-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2020. | | Management | | For | | | |
| 2. | | To confirm dividends. | | Management | | For | | | |
| 3. | | To reappoint PricewaterhouseCoopers LLP as Auditor. | | Management | | For | | | |
| 4. | | To authorise the Directors to agree the remuneration of the Auditor. | | Management | | For | | | |
| 5A. | | Re-election of Director: Leif Johansson | | Management | | For | | | |
| 5B. | | Re-election of Director: Pascal Soriot | | Management | | For | | | |
| 5C. | | Re-election of Director: Marc Dunoyer | | Management | | For | | | |
| 5D. | | Re-election of Director: Philip Broadley | | Management | | For | | | |
| 5E. | | Election of Director: Euan Ashley | | Management | | For | | | |
| 5F. | | Re-election of Director: Michel Demaré | | Management | | For | | | |
| 5G. | | Re-election of Director: Deborah DiSanzo | | Management | | For | | | |
| 5H. | | Election of Director: Diana Layfield | | Management | | For | | | |
| 5I. | | Re-election of Director: Sheri McCoy | | Management | | For | | | |
| 5J. | | Re-election of Director: Tony Mok | | Management | | For | | | |
| 5K. | | Re-election of Director: Nazneen Rahman | | Management | | For | | | |
| 5L. | | Re-election of Director: Marcus Wallenberg | | Management | | For | | | |
| 6. | | To approve the Annual Report on Remuneration for the year ended 31 December 2020. | | Management | | For | | | |
| 7. | | To approve the Directors' Remuneration Policy. | | Management | | For | | | |
| 8. | | To authorise limited political donations. | | Management | | For | | | |
| 9. | | To authorise the Directors to allot shares. | | Management | | For | | | |
| 10. | | Special Resolution: To authorise the Directors to disapply pre- emption rights. | | Management | | For | | | |
| 11. | | Special Resolution: To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments. | | Management | | For | | | |
| 12. | | Special Resolution: To authorise the Company to purchase its own shares. | | Management | | For | | | |
| 13. | | Special Resolution: To reduce the notice period for general meetings. | | Management | | For | | | |
| 14. | | To approve amendments to the Performance Share Plan 2020. | | Management | | For | | | |
ASTRAZENECA PLC
| Security | 046353108 | Meeting Type | Annual |
| Ticker Symbol | AZN | Meeting Date | 11-May-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | (a) the proposed acquisition by the Company of Alexion Pharmaceuticals, Inc. and the associated arrangements to be entered into, all as described in the circular to the shareholders of the Company dated 12 April 2021 and substantially on the terms and subject to the conditions set out in the Merger Agreement dated 12 December 2020 between the Company and Alexion Pharmaceuticals, Inc. (among others) (the "Transaction"), be and is hereby approved; and (b) the directors ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | | |
ASTRAZENECA PLC
| Security | 046353108 | Meeting Type | Annual |
| Ticker Symbol | AZN | Meeting Date | 11-May-2021 |
| Record Date | 19-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2020. | | Management | | For | | | |
| 2. | | To confirm dividends. | | Management | | For | | | |
| 3. | | To reappoint PricewaterhouseCoopers LLP as Auditor. | | Management | | For | | | |
| 4. | | To authorise the Directors to agree the remuneration of the Auditor. | | Management | | For | | | |
| 5A. | | Re-election of Director: Leif Johansson | | Management | | For | | | |
| 5B. | | Re-election of Director: Pascal Soriot | | Management | | For | | | |
| 5C. | | Re-election of Director: Marc Dunoyer | | Management | | For | | | |
| 5D. | | Re-election of Director: Philip Broadley | | Management | | For | | | |
| 5E. | | Election of Director: Euan Ashley | | Management | | For | | | |
| 5F. | | Re-election of Director: Michel Demaré | | Management | | For | | | |
| 5G. | | Re-election of Director: Deborah DiSanzo | | Management | | For | | | |
| 5H. | | Election of Director: Diana Layfield | | Management | | For | | | |
| 5I. | | Re-election of Director: Sheri McCoy | | Management | | For | | | |
| 5J. | | Re-election of Director: Tony Mok | | Management | | For | | | |
| 5K. | | Re-election of Director: Nazneen Rahman | | Management | | For | | | |
| 5L. | | Re-election of Director: Marcus Wallenberg | | Management | | For | | | |
| 6. | | To approve the Annual Report on Remuneration for the year ended 31 December 2020. | | Management | | For | | | |
| 7. | | To approve the Directors' Remuneration Policy. | | Management | | For | | | |
| 8. | | To authorise limited political donations. | | Management | | For | | | |
| 9. | | To authorise the Directors to allot shares. | | Management | | For | | | |
| 10. | | Special Resolution: To authorise the Directors to disapply pre- emption rights. | | Management | | For | | | |
| 11. | | Special Resolution: To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments. | | Management | | For | | | |
| 12. | | Special Resolution: To authorise the Company to purchase its own shares. | | Management | | For | | | |
| 13. | | Special Resolution: To reduce the notice period for general meetings. | | Management | | For | | | |
| 14. | | To approve amendments to the Performance Share Plan 2020. | | Management | | For | | | |
ASTRAZENECA PLC
| Security | 046353108 | Meeting Type | Annual |
| Ticker Symbol | AZN | Meeting Date | 11-May-2021 |
| Record Date | 20-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | (a) the proposed acquisition by the Company of Alexion Pharmaceuticals, Inc. and the associated arrangements to be entered into, all as described in the circular to the shareholders of the Company dated 12 April 2021 and substantially on the terms and subject to the conditions set out in the Merger Agreement dated 12 December 2020 between the Company and Alexion Pharmaceuticals, Inc. (among others) (the "Transaction"), be and is hereby approved; and (b) the directors ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | | |
ATRECA INC
| Security | 04965G109 | Meeting Type | Annual |
| Ticker Symbol | BCEL | Meeting Date | 09-Jun-2021 |
| Record Date | 15-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Brian Atwood | | | | For | | For | |
| | | 2 | W. H. Robinson, M.D PhD | | | | For | | For | |
| | | 3 | Tito A. Serafini, Ph.D. | | | | For | | For | |
| 2. | | Ratification of the selection of OUM & Co. LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021. | | Management | | For | | For | |
AVADEL PHARMACEUTICALS PLC
| Security | 05337M104 | Meeting Type | Annual |
| Ticker Symbol | AVDL | Meeting Date | 05-Aug-2020 |
| Record Date | 27-May-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | By separate resolutions, to elect the following six current Directors: Gregory J. Divis, Dr. Eric J. Ende, Geoffrey M. Glass, Linda S. Palczuk, Dr. Mark A. McCamish and Peter Thornton to the Board of Directors (the "Board"); each to serve a one year term expiring at the conclusion of the next annual general meeting of shareholders ("Proposal 1"). | | Management | | For | | For | |
| 2. | | To ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP as the Company's independent registered public auditor and accounting firm for the fiscal year ending December 31, 2020 and to authorize, in a binding vote, the Audit Committee of the Board to set the independent registered public auditor and accounting firm remuneration ("Proposal 2"). | | Management | | For | | For | |
| 3. | | To approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company ("Proposal 3"). | | Management | | For | | For | |
| 4. | | To approve the Avadel Pharmaceuticals plc 2020 Omnibus Incentive Compensation Plan ("Proposal 4"). | | Management | | For | | For | |
BAYER AG
| Security | D0712D163 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 27-Apr-2021 |
| Record Date | 20-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | DISTRIBUTION OF THE PROFIT | | Management | | For | | For | |
| 2 | | RATIFICATION OF THE ACTIONS OF THE MEMBERS OF THE BOARD OF MANAGEMENT | | Management | | For | | For | |
| 3 | | RATIFICATION OF THE ACTIONS OF THE MEMBERS OF THE SUPERVISORY BOARD | | Management | | For | | For | |
| 4.1 | | SUPERVISORY BOARD ELECTION: DR. FEI-FEI LI | | Management | | For | | For | |
| 4.2 | | SUPERVISORY BOARD ELECTION: ALBERTO WEISSER | | Management | | For | | For | |
| 5 | | COMPENSATION OF THE SUPERVISORY BOARD - AMENDMENT TO THE ARTICLES OF INCORPORATION | | Management | | For | | For | |
| 6 | | ELECTION OF THE AUDITOR (FULL-YEAR, HALF- YEAR AND Q3 2021; Q1 2022) | | Management | | For | | For | |
BECTON, DICKINSON AND COMPANY
| Security | 075887109 | Meeting Type | Annual |
| Ticker Symbol | BDX | Meeting Date | 26-Jan-2021 |
| Record Date | 07-Dec-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Catherine M. Burzik | | Management | | For | | For | |
| 1B. | | Election of Director: R. Andrew Eckert | | Management | | For | | For | |
| 1C. | | Election of Director: Vincent A. Forlenza | | Management | | For | | For | |
| 1D. | | Election of Director: Claire M. Fraser | | Management | | For | | For | |
| 1E. | | Election of Director: Jeffrey W. Henderson | | Management | | For | | For | |
| 1F. | | Election of Director: Christopher Jones | | Management | | For | | For | |
| 1G. | | Election of Director: Marshall O. Larsen | | Management | | For | | For | |
| 1H. | | Election of Director: David F. Melcher | | Management | | For | | For | |
| 1I. | | Election of Director: Thomas E. Polen | | Management | | For | | For | |
| 1J. | | Election of Director: Claire Pomeroy | | Management | | For | | For | |
| 1K. | | Election of Director: Rebecca W. Rimel | | Management | | For | | For | |
| 1L. | | Election of Director: Timothy M. Ring | | Management | | For | | For | |
| 1M. | | Election of Director: Bertram L. Scott | | Management | | For | | For | |
| 2. | | Ratification of the selection of the independent registered public accounting firm. | | Management | | For | | For | |
| 3. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
| 4. | | Shareholder proposal seeking to lower the ownership threshold required to call a special shareholders meeting, if properly presented at the meeting. | | Shareholder | | Against | | For | |
BIOGEN INC.
| Security | 09062X103 | Meeting Type | Annual |
| Ticker Symbol | BIIB | Meeting Date | 02-Jun-2021 |
| Record Date | 09-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Alexander J. Denner | | Management | | For | | For | |
| 1B. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Caroline D. Dorsa | | Management | | For | | For | |
| 1C. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Maria C. Freire | | Management | | For | | For | |
| 1D. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: William A. Hawkins | | Management | | For | | For | |
| 1E. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: William D. Jones | | Management | | For | | For | |
| 1F. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Nancy L. Leaming | | Management | | For | | For | |
| 1G. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Jesus B. Mantas | | Management | | For | | For | |
| 1H. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Richard C. Mulligan | | Management | | For | | For | |
| 1I. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Stelios Papadopoulos | | Management | | For | | For | |
| 1J. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Brian S. Posner | | Management | | For | | For | |
| 1K. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Eric K. Rowinsky | | Management | | For | | For | |
| 1L. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Stephen A. Sherwin | | Management | | For | | For | |
| 1M. | | Election of Director to serve for a one-year term extending until the 2022 annual meeting: Michel Vounatsos | | Management | | For | | For | |
| 2. | | To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | Say on Pay - To approve an advisory vote on executive compensation. | | Management | | For | | For | |
| 4. | | To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add a federal forum selection provision. | | Management | | For | | For | |
| 5. | | Stockholder proposal requesting a report on Biogen's lobbying activities. | | Shareholder | | Against | | For | |
| 6. | | Stockholder proposal requesting a report on Biogen's gender pay gap. | | Shareholder | | Against | | For | |
BOSTON SCIENTIFIC CORPORATION
| Security | 101137107 | Meeting Type | Annual |
| Ticker Symbol | BSX | Meeting Date | 06-May-2021 |
| Record Date | 12-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Nelda J. Connors | | Management | | For | | For | |
| 1B. | | Election of Director: Charles J. Dockendorff | | Management | | For | | For | |
| 1C. | | Election of Director: Yoshiaki Fujimori | | Management | | For | | For | |
| 1D. | | Election of Director: Donna A. James | | Management | | For | | For | |
| 1E. | | Election of Director: Edward J. Ludwig | | Management | | For | | For | |
| 1F. | | Election of Director: Michael F. Mahoney | | Management | | For | | For | |
| 1G. | | Election of Director: David J. Roux | | Management | | For | | For | |
| 1H. | | Election of Director: John E. Sununu | | Management | | For | | For | |
| 1I. | | Election of Director: Ellen M. Zane | | Management | | For | | For | |
| 2. | | To approve, on a non-binding, advisory basis, named executive officer compensation. | | Management | | For | | For | |
| 3. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2021 fiscal year. | | Management | | For | | For | |
| 4. | | To consider and vote upon a stockholder proposal requesting a report to stockholders describing any benefits to the company related to employee participation in company governance. | | Shareholder | | Against | | For | |
BRISTOL-MYERS SQUIBB COMPANY
| Security | 110122108 | Meeting Type | Annual |
| Ticker Symbol | BMY | Meeting Date | 04-May-2021 |
| Record Date | 15-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A) | | Election of Director: Peter J. Arduini | | Management | | For | | For | |
| 1B) | | Election of Director: Michael W. Bonney | | Management | | For | | For | |
| 1C) | | Election of Director: Giovanni Caforio, M.D. | | Management | | For | | For | |
| 1D) | | Election of Director: Julia A. Haller, M.D. | | Management | | For | | For | |
| 1E) | | Election of Director: Paula A. Price | | Management | | For | | For | |
| 1F) | | Election of Director: Derica W. Rice | | Management | | For | | For | |
| 1G) | | Election of Director: Theodore R. Samuels | | Management | | For | | For | |
| 1H) | | Election of Director: Gerald L. Storch | | Management | | For | | For | |
| 1I) | | Election of Director: Karen Vousden, Ph.D. | | Management | | For | | For | |
| 1J) | | Election of Director: Phyllis R. Yale | | Management | | For | | For | |
| 2. | | Advisory Vote to Approve the Compensation of our Named Executive Officers. | | Management | | For | | For | |
| 3. | | Approval of the Company's 2021 Stock Award and Incentive Plan. | | Management | | For | | For | |
| 4. | | Ratification of the Appointment of an Independent Registered Public Accounting Firm. | | Management | | For | | For | |
| 5. | | Approval of an Amendment to the Certificate of Incorporation to Lower the Ownership Threshold for Special Shareholder Meetings to 15%. | | Management | | For | | For | |
| 6. | | Shareholder Proposal on Adoption of a Board Policy that the Chairperson of the Board be an Independent Director. | | Shareholder | | For | | Against | |
| 7. | | Shareholder Proposal on Shareholder Right to Act by Written Consent. | | Shareholder | | Against | | For | |
| 8. | | Shareholder Proposal to Lower the Ownership Threshold for Special Shareholder Meetings to 10%. | | Shareholder | | Against | | For | |
CELLDEX THERAPEUTICS, INC.
| Security | 15117B202 | Meeting Type | Annual |
| Ticker Symbol | CLDX | Meeting Date | 17-Jun-2021 |
| Record Date | 20-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Karen L. Shoos | | | | For | | For | |
| | | 2 | Anthony S. Marucci | | | | For | | For | |
| | | 3 | Keith L. Brownlie | | | | For | | For | |
| | | 4 | Herbert J. Conrad | | | | For | | For | |
| | | 5 | James J. Marino | | | | For | | For | |
| | | 6 | Harry H. Penner, Jr. | | | | For | | For | |
| 2. | | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | To approve our 2021 Omnibus Equity Incentive Plan. | | Management | | For | | For | |
| 4. | | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. | | Management | | For | | For | |
CELLECTIS S.A.
| Security | 15117K103 | Meeting Type | Special |
| Ticker Symbol | CLLS | Meeting Date | 04-Nov-2020 |
| Record Date | 06-Oct-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| O1 | | Appointment of Mr. Jean-Pierre Garnier as a new board member. | | Management | | For | | For | |
| E2 | | Amendment to the age limit applicable to directors, the chief executive officer and deputy chief executive officers. | | Management | | For | | For | |
CELLECTIS S.A.
| Security | 15117K103 | Meeting Type | Special |
| Ticker Symbol | CLLS | Meeting Date | 04-Nov-2020 |
| Record Date | 20-Oct-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| O1 | | Appointment of Mr. Jean-Pierre Garnier as a new board member. | | Management | | For | | For | |
| E2 | | Amendment to the age limit applicable to directors, the chief executive officer and deputy chief executive officers. | | Management | | For | | For | |
CELLECTIS S.A.
| Security | 15117K103 | Meeting Type | Annual |
| Ticker Symbol | CLLS | Meeting Date | 01-Jun-2021 |
| Record Date | 30-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| O1 | | Resolution 1: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O2 | | Resolution 2: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O3 | | Resolution 3: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O4 | | Resolution 4: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O5 | | Resolution 5: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O6 | | Resolution 6: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O7 | | Resolution 7: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O8 | | Resolution 8: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O9 | | Resolution 9: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E10 | | Resolution 10: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E11 | | Resolution 11: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E12 | | Resolution 12: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E13 | | Resolution 13: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E14 | | Resolution 14: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E15 | | Resolution 15: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E16 | | Resolution 16: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E17 | | Resolution 17: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E18 | | Resolution 18: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E19 | | Resolution 19: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E20 | | Resolution 20: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E21 | | Resolution 21: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E22 | | Resolution 22: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E23 | | Resolution 23: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E24 | | Resolution 24: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E25 | | Resolution 25: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | Against | |
CELLECTIS S.A.
| Security | 15117K103 | Meeting Type | Annual |
| Ticker Symbol | CLLS | Meeting Date | 01-Jun-2021 |
| Record Date | 18-May-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| O1 | | Resolution 1: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O2 | | Resolution 2: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O3 | | Resolution 3: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O4 | | Resolution 4: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O5 | | Resolution 5: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O6 | | Resolution 6: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O7 | | Resolution 7: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O8 | | Resolution 8: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| O9 | | Resolution 9: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E10 | | Resolution 10: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E11 | | Resolution 11: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E12 | | Resolution 12: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E13 | | Resolution 13: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E14 | | Resolution 14: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E15 | | Resolution 15: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E16 | | Resolution 16: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E17 | | Resolution 17: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E18 | | Resolution 18: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E19 | | Resolution 19: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E20 | | Resolution 20: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E21 | | Resolution 21: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E22 | | Resolution 22: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E23 | | Resolution 23: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E24 | | Resolution 24: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | For | |
| E25 | | Resolution 25: Please see attached copy of the Company's Notice of Meeting for details. | | Management | | For | | Against | |
CENTENE CORPORATION
| Security | 15135B101 | Meeting Type | Annual |
| Ticker Symbol | CNC | Meeting Date | 27-Apr-2021 |
| Record Date | 26-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Jessica L. Blume | | Management | | For | | For | |
| 1B. | | Election of Director: Frederick H. Eppinger | | Management | | For | | For | |
| 1C. | | Election of Director: David L. Steward | | Management | | For | | For | |
| 1D. | | Election of Director: William L. Trubeck | | Management | | For | | For | |
| 2. | | ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION. | | Management | | For | | For | |
| 3. | | RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2021. | | Management | | For | | For | |
| 4. | | APPROVAL OF THE AMENDMENT TO THE 2012 STOCK INCENTIVE PLAN, AS AMENDED. | | Management | | For | | For | |
| 5. | | APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY'S CERTIFICATE OF INCORPORATION AS DESCRIBED IN THE PROXY STATEMENT. | | Management | | For | | For | |
| 6. | | THE STOCKHOLDER PROPOSAL TO ELECT EACH DIRECTOR ANNUALLY AS DESCRIBED IN THE PROXY STATEMENT. | | Shareholder | | For | | For | |
CIGNA CORPORATION
| Security | 125523100 | Meeting Type | Annual |
| Ticker Symbol | CI | Meeting Date | 28-Apr-2021 |
| Record Date | 08-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: David M. Cordani | | Management | | For | | For | |
| 1B. | | Election of Director: William J. DeLaney | | Management | | For | | For | |
| 1C. | | Election of Director: Eric J. Foss | | Management | | For | | For | |
| 1D. | | Election of Director: Elder Granger, MD, MG, USA (Retired) | | Management | | For | | For | |
| 1E. | | Election of Director: Isaiah Harris, Jr. | | Management | | For | | For | |
| 1F. | | Election of Director: George Kurian | | Management | | For | | For | |
| 1G. | | Election of Director: Kathleen M. Mazzarella | | Management | | For | | For | |
| 1H. | | Election of Director: Mark B. McClellan, MD, PhD | | Management | | For | | For | |
| 1I. | | Election of Director: John M. Partridge | | Management | | For | | For | |
| 1J. | | Election of Director: Kimberly A. Ross | | Management | | For | | For | |
| 1K. | | Election of Director: Eric C. Wiseman | | Management | | For | | For | |
| 1L. | | Election of Director: Donna F. Zarcone | | Management | | For | | For | |
| 2. | | Advisory approval of Cigna's executive compensation. | | Management | | For | | For | |
| 3. | | Approval of the Amended and Restated Cigna Long- Term Incentive Plan. | | Management | | For | | For | |
| 4. | | Ratification of the appointment of PricewaterhouseCoopers LLP as Cigna's independent registered public accounting firm for 2021. | | Management | | For | | For | |
| 5. | | Shareholder proposal - Shareholder right to act by written consent. | | Shareholder | | Against | | For | |
| 6. | | Shareholder proposal - Gender pay gap report. | | Shareholder | | Against | | For | |
| 7. | | Shareholder proposal - Board ideology disclosure policy. | | Shareholder | | Against | | For | |
COMMUNITY HEALTH SYSTEMS, INC.
| Security | 203668108 | Meeting Type | Annual |
| Ticker Symbol | CYH | Meeting Date | 11-May-2021 |
| Record Date | 15-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: John A. Clerico | | Management | | For | | For | |
| 1B. | | Election of Director: Michael Dinkins | | Management | | For | | For | |
| 1C. | | Election of Director: James S. Ely III | | Management | | For | | For | |
| 1D. | | Election of Director: John A. Fry | | Management | | For | | For | |
| 1E. | | Election of Director: Tim L. Hingtgen | | Management | | For | | For | |
| 1F. | | Election of Director: Elizabeth T. Hirsch | | Management | | For | | For | |
| 1G. | | Election of Director: William Norris Jennings, M.D. | | Management | | For | | For | |
| 1H. | | Election of Director: K. Ranga Krishnan, MBBS | | Management | | For | | For | |
| 1I. | | Election of Director: Julia B. North | | Management | | For | | For | |
| 1J. | | Election of Director: Wayne T. Smith | | Management | | For | | For | |
| 1K. | | Election of Director: H. James Williams, Ph.D. | | Management | | For | | For | |
| 2. | | Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. | | Management | | For | | For | |
| 3. | | Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors on March 17, 2021, subject to stockholder approval. | | Management | | For | | For | |
| 4. | | Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
COMMUNITY HEALTHCARE TRUST INCORPORATED
| Security | 20369C106 | Meeting Type | Annual |
| Ticker Symbol | CHCT | Meeting Date | 06-May-2021 |
| Record Date | 05-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Alan Gardner | | | | For | | For | |
| | | 2 | Claire Gulmi | | | | For | | For | |
| | | 3 | Robert Hensley | | | | For | | For | |
| | | 4 | Lawrence Van Horn | | | | For | | For | |
| | | 5 | Timothy Wallace | | | | For | | For | |
| 2. | | To approve, on a non-binding advisory basis, the following resolutions: RESOLVED, that the stockholders of Community Healthcare Trust Incorporated approve, on a non-binding advisory basis, the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2021 annual meeting of stockholders. | | Management | | For | | For | |
| 3. | | To ratify the appointment of BDO USA, LLP as the Company's independent registered public accountants for 2021. | | Management | | For | | For | |
CSL LTD
| Security | Q3018U109 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 14-Oct-2020 |
| Record Date | 12-Oct-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 2.A | | TO RE-ELECT MR BRUCE BROOK AS DIRECTOR | | Management | | For | | For | |
| 2.B | | TO ELECT MS CAROLYN HEWSON AO AS DIRECTOR | | Management | | For | | For | |
| 2.C | | TO ELECT MR PASCAL SORIOT AS DIRECTOR | | Management | | For | | For | |
| 3 | | ADOPTION OF THE REMUNERATION REPORT | | Management | | For | | For | |
| 4 | | APPROVAL OF A GRANT OF PERFORMANCE SHARE UNITS TO THE CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR, MR PAUL PERREAULT | | Management | | For | | For | |
CVS HEALTH CORPORATION
| Security | 126650100 | Meeting Type | Annual |
| Ticker Symbol | CVS | Meeting Date | 13-May-2021 |
| Record Date | 17-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Fernando Aguirre | | Management | | For | | For | |
| 1B. | | Election of Director: C. David Brown II | | Management | | For | | For | |
| 1C. | | Election of Director: Alecia A. DeCoudreaux | | Management | | For | | For | |
| 1D. | | Election of Director: Nancy-Ann M. DeParle | | Management | | For | | For | |
| 1E. | | Election of Director: David W. Dorman | | Management | | For | | For | |
| 1F. | | Election of Director: Roger N. Farah | | Management | | For | | For | |
| 1G. | | Election of Director: Anne M. Finucane | | Management | | For | | For | |
| 1H. | | Election of Director: Edward J. Ludwig | | Management | | For | | For | |
| 1I. | | Election of Director: Karen S. Lynch | | Management | | For | | For | |
| 1J. | | Election of Director: Jean-Pierre Millon | | Management | | For | | For | |
| 1K. | | Election of Director: Mary L. Schapiro | | Management | | For | | For | |
| 1L. | | Election of Director: William C. Weldon | | Management | | For | | For | |
| 1M. | | Election of Director: Tony L. White | | Management | | For | | For | |
| 2. | | Ratification of the appointment of our independent registered public accounting firm for 2021. | | Management | | For | | For | |
| 3. | | Say on Pay, a proposal to approve, on an advisory basis, the Company's executive compensation. | | Management | | For | | For | |
| 4. | | Stockholder proposal for reducing the threshold for our stockholder right to act by written consent. | | Shareholder | | Against | | For | |
| 5. | | Stockholder proposal regarding our independent Board Chair. | | Shareholder | | Against | | For | |
DAIICHI SANKYO COMPANY,LIMITED
| Security | J11257102 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 21-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1 | | Approve Appropriation of Surplus | | Management | | For | | For | |
| 2.1 | | Appoint a Director Manabe, Sunao | | Management | | For | | For | |
| 2.2 | | Appoint a Director Kimura, Satoru | | Management | | For | | For | |
| 2.3 | | Appoint a Director Otsuki, Masahiko | | Management | | For | | For | |
| 2.4 | | Appoint a Director Hirashima, Shoji | | Management | | For | | For | |
| 2.5 | | Appoint a Director Uji, Noritaka | | Management | | For | | For | |
| 2.6 | | Appoint a Director Fukui, Tsuguya | | Management | | For | | For | |
| 2.7 | | Appoint a Director Kama, Kazuaki | | Management | | For | | For | |
| 2.8 | | Appoint a Director Nohara, Sawako | | Management | | For | | For | |
| 2.9 | | Appoint a Director Okuzawa, Hiroyuki | | Management | | For | | For | |
| 3 | | Appoint a Corporate Auditor Watanabe, Masako | | Management | | For | | For | |
| 4 | | Approve Payment of Bonuses to Directors | | Management | | For | | For | |
| 5 | | Approve Details of the Compensation to be received by Directors | | Management | | For | | For | |
| 6 | | Approve Details of the Compensation to be received by Corporate Auditors | | Management | | For | | For | |
| 7 | | Approve Details of the Performance-based Stock Compensation to be received by Directors, etc. | | Management | | For | | For | |
DANAHER CORPORATION
| Security | 235851102 | Meeting Type | Annual |
| Ticker Symbol | DHR | Meeting Date | 05-May-2021 |
| Record Date | 08-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director to hold office until the 2022 Annual Meeting: Rainer M. Blair | | Management | | For | | For | |
| 1B. | | Election of Director to hold office until the 2022 Annual Meeting: Linda Hefner Filler | | Management | | For | | For | |
| 1C. | | Election of Director to hold office until the 2022 Annual Meeting: Teri List | | Management | | For | | For | |
| 1D. | | Election of Director to hold office until the 2022 Annual Meeting: Walter G. Lohr, Jr. | | Management | | For | | For | |
| 1E. | | Election of Director to hold office until the 2022 Annual Meeting: Jessica L. Mega, MD | | Management | | For | | For | |
| 1F. | | Election of Director to hold office until the 2022 Annual Meeting: Mitchell P. Rales | | Management | | For | | For | |
| 1G. | | Election of Director to hold office until the 2022 Annual Meeting: Steven M. Rales | | Management | | For | | For | |
| 1H. | | Election of Director to hold office until the 2022 Annual Meeting: Pardis C. Sabeti, MD | | Management | | For | | For | |
| 1I. | | Election of Director to hold office until the 2022 Annual Meeting: John T. Schwieters | | Management | | For | | For | |
| 1J. | | Election of Director to hold office until the 2022 Annual Meeting: Alan G. Spoon | | Management | | For | | For | |
| 1K. | | Election of Director to hold office until the 2022 Annual Meeting: Raymond C. Stevens, Ph.D | | Management | | For | | For | |
| 1L. | | Election of Director to hold office until the 2022 Annual Meeting: Elias A. Zerhouni, MD | | Management | | For | | For | |
| 2. | | To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | To approve on an advisory basis the Company's named executive officer compensation. | | Management | | For | | For | |
| 4. | | To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10%. | | Shareholder | | Against | | For | |
DECIPHER BIOSCIENCES, INC.
| Security | N/A | Meeting Type | Written Consent |
| Ticker Symbol | N/A | Meeting Date | 23-Jul-2020 |
| Record Date | N/A | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | Amendment of 2018 Equity Incentive Plan | | Management | | For | | For | |
| 2. | | General Authorizing Resolution | | Management | | For | | For | |
DECIPHER BIOSCIENCES, INC.
| Security | N/A | Meeting Type | Written Consent |
| Ticker Symbol | N/A | Meeting Date | 1-Mar-2021 |
| Record Date | N/A | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | Approval of Merger and Agreement and Plan of Merger | | Management | | For | | For | |
| 2. | | Waiver of Notice Rquirements | | Management | | For | | For | |
| 3 | | Waiver of Appraisal Rights | | Management | | For | | For | |
| 4 | | Termination of Stockholder Agreements | | Management | | For | | For | |
DENTSPLY SIRONA INC.
| Security | 24906P109 | Meeting Type | Annual |
| Ticker Symbol | XRAY | Meeting Date | 26-May-2021 |
| Record Date | 29-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Eric K. Brandt | | Management | | For | | For | |
| 1B. | | Election of Director: Donald M. Casey Jr. | | Management | | For | | For | |
| 1C. | | Election of Director: Willie A. Deese | | Management | | For | | For | |
| 1D. | | Election of Director: Betsy D. Holden | | Management | | For | | For | |
| 1E. | | Election of Director: Clyde R. Hosein | | Management | | For | | For | |
| 1F. | | Election of Director: Arthur D. Kowaloff | | Management | | For | | For | |
| 1G. | | Election of Director: Harry M. Kraemer Jr. | | Management | | For | | For | |
| 1H. | | Election of Director: Gregory T. Lucier | | Management | | For | | For | |
| 1I. | | Election of Director: Leslie F. Varon | | Management | | For | | For | |
| 1J. | | Election of Director: Janet S. Vergis | | Management | | For | | For | |
| 2. | | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for 2021. | | Management | | For | | For | |
| 3. | | Approval, by non-binding vote, of the Company's executive compensation. | | Management | | For | | For | |
DEXCOM, INC.
| Security | 252131107 | Meeting Type | Annual |
| Ticker Symbol | DXCM | Meeting Date | 20-May-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Election of Class I Director to hold office until 2024 Annual Meeting: Kevin R. Sayer | | Management | | For | | For | |
| 1.2 | | Election of Class I Director to hold office until 2024 Annual Meeting: Nicholas Augustinos | | Management | | For | | For | |
| 1.3 | | Election of Class I Director to hold office until 2024 Annual Meeting: Bridgette P. Heller | | Management | | For | | For | |
| 2. | | To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | To hold a non-binding vote on an advisory resolution to approve executive compensation. | | Management | | For | | For | |
| 4. | | To approve the amendment and restatement of our Certificate of Incorporation to declassify our Board of Directors. | | Management | | For | | For | |
DIVERSIFIED HEALTHCARE TRUST
| Security | 25525P107 | Meeting Type | Annual |
| Ticker Symbol | DHC | Meeting Date | 03-Jun-2021 |
| Record Date | 24-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Independent Trustee: Lisa Harris Jones | | Management | | For | | For | |
| 1B. | | Election of Managing Trustee: Jennifer F. Francis (Mintzer) | | Management | | For | | For | |
| 2. | | Advisory vote to approve executive compensation. | | Management | | For | | For | |
| 3. | | Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2021 fiscal year. | | Management | | For | | For | |
DYNACURE
| Security | N/A | Meeting Type | Written Consent |
| Ticker Symbol | N/A | Meeting Date | 18-Sep-2020 |
| Record Date | N/A | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | Waiver of the procedures for convening meetings and the time limits for the provision of documents and information provided for by the laws and regulations in force | | Management | | For | | For | |
| 2 | | Review and approval of the delegation of competence to be granted to the CEO in order to decide to increase the share capital with cancellation of the preferential subscription right, by contribution in cash of a maximum amount with EUR 21,206.40 through the issuance of a maximum number of 212,064 ABSA C with a nominal value of ten cents (0.10 ) each and an issue premium of EUR 21.12 each, i.e. an aggregate amount of issue premium of EUR 4,478,791.68 and a total subscription price of EUR 4,499,998.08 | | Management | | For | | For | |
| 3 | | Review and approval of the cancellation of the preferential subscription right of the Shareholders in favor of French and/or foreign investment funds and/or companies | | Management | | For | | For | |
| 4 | | Review and approval of the delegation of competence to be granted to the CEO to decide the issuance and allocation of a maximum number of 198,014 SO | | Management | | For | | For | |
| 5 | | Review and approval of the delegation of competence to be granted to the CEO to decide the issuance and allocation of a maximum number of 198,014 BSA2020 | | Management | | For | | For | |
| 6 | | Proposal to cancel the preferential subscription right of the Shareholders with respect to the BSA 2020 in favor of determined categories of beneficiaries | | Management | | For | | For | |
| 7 | | Review and approval of the delegation of competence granted to the CEO to decide the issuance and allocation of 198,014 AGA2020 | | Management | | For | | For | |
| 8 | | Review and approval of a delegation of competence to be granted to the CEO to decide to increase the share capital with cancellation of the preferential subscription right, by contribution in cash of a maximum amount with EUR 58,906.60 through the issuance of a maximum number of 589,066 ABSA C T1 with a nominal value of ten cents (0.10€) each | | Management | | For | | For | |
| 9 | | Review and approval of the cancellation of the preferential subscription right of the Shareholders in favor of French and/or foreign investment funds and/or companies | | Management | | For | | For | |
| 10 | | Amendment of articles 7.4, 14.4 and 14.6 of the Company's bylaws | | Management | | For | | For | |
| 11 | | Share capital increase with cancellation of the preferential subscription right in favor of employes pursuant to the conditions of articles L: 3332-18 of the French labor code, in accordance withi the provisions of article L.225-129-6 of the French commercial code | | Management | | For | | For | |
| 12 | | Powers for formalities | | Management | | For | | For | |
DYNACURE
| Security | N/A | Meeting Type | Written Consent |
| Ticker Symbol | N/A | Meeting Date | 15-Oct-2020 |
| Record Date | N/A | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | Waiver of the Conditions of Second Tranche Mandatory Exercise | | Management | | For | | For | |
DYNACURE
| Security | N/A | Meeting Type | General Meeting |
| Ticker Symbol | N/A | Meeting Date | 10-Nov-2020 |
| Record Date | N/A | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | Waiver of the prior notice period and of the period for provision of the documents pursuant to the laws and regulations in force | | Management | | For | | For | |
| 2 | | Conversion of the Company into a public limited company with a board of directors (societe anonyme a conseil d'administration) | | Management | | For | | For | |
| 3 | | Adoption of new restated bylaws of the Company | | Management | | For | | For | |
| 4 | | Acknowledgement of termination of the terms of offices of the President and all members and censors of the Supervisory Board | | Management | | For | | For | |
| 5 | | Appointment of the first directors of the Company in its form as a public limited company (societe anonyme) | | Management | | For | | For | |
| 6 | | Determination of the remuneration allocated to the directors | | Management | | For | | For | |
| 7 | | Creation of a committee of censors | | Management | | For | | For | |
| 8 | | Confirmation of the functions of the Company's statutory auditors | | Management | | For | | For | |
| 9 | | Provisions relating to the financial accounts of the Company | | Management | | For | | For | |
| 10 | | Acknowledgement of the conversion of the Company into a public limited company (societe anonyme) | | Management | | For | | For | |
| 11 | | Review and approval of the delegation of competence to be granted to the Board of Directors to decide the issuance and allocation of a maximumnumber of 323,968 SO | | Management | | For | | For | |
| 12 | | Review and approval of the delegation of competence to be granted to the Board of Directors to decide the issuance and allocation of a maximum number of 323,968 BSA 2020 | | Management | | For | | For | |
| 13 | | Proposal to cancel the Shareholders' preferential subscription right with respect to the BSA2020 in favor of determined categories of beneficiaries | | Management | | For | | For | |
| 14 | | Review and approval of the delegation of competence granted to the Board of Directors to decide the issuance and allocation of 323,968 AGA 2020 | | Management | | For | | For | |
| 15 | | Share capital increae with cancellation of the preferential subscription right in favor of employees pursuant to the conditions of articles L. 3332-18 of the French Labor Code, in accordance with the provisions of article L.225-129-6 of the French Commercial Code | | Management | | Against | | Against | |
| 16 | | Powers to carry out formalities | | Management | | For | | For | |
DYNACURE
| Security | N/A | Meeting Type | Ordinary General Meeting |
| Ticker Symbol | N/A | Meeting Date | 5-Jan-2021 |
| Record Date | N/A | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | Appointment of Mrs. Jean Franchi as a new member of the board of directors | | Management | | For | | For | |
| 2 | | Determination of the compensation to be allocated to the members of the board of directors | | Management | | For | | For | |
| 3 | | Powers to carry out formalities | | Management | | For | | For | |
DYNACURE
| Security | N/A | Meeting Type | Combined General Meeting |
| Ticker Symbol | N/A | Meeting Date | 28-Jun-2021 |
| Record Date | N/A | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | Approval of annual financial statements for the fiscal year ended December 31, 2020 and discharge of the Chairman of the Board of Directors, the CEO, the Directors and the statutory auditors performance during the past year. | | | | For | | For | |
| 2 | | Allocation of the result for the fiscal year ended December 31, 2020 | | | | For | | For | |
| 3 | | Review of the agreements referred to in Articles L 225-38 et seq. of the French Commercial Code | | | | For | | For | |
| 4 | | Renewal/ duration of the terms of office of directors | | | | For | | For | |
| 5 | | Renewal of the terms of the office of observers | | | | For | | For | |
| 6 | | Delegation of autority to the Board of Directors to increase the share capital by issuing ordinary shares, or any securities giving access to the Company's share capital, with shareholders ' preferential subscription right | | | | For | | For | |
| 7 | | Delegation of authority to the Board of Directors to increase the share capital by issuing ordinary shares, or any securities giving access to the Company's share capital, without shareholders' preferential subscription right, by way of a public offering excluding offerings referred to in article L. 411-2 1 of the French Monetary and Financial Code | | | | For | | For | |
| 8 | | Delegation of authority to the Board of Directors to increase the share capital by ussuing ordinary shares, or any securities giving access to the Company's share capital, without shareholders' preferential subscription right, by way of a public offering referred to in article L. 411-2 1 of the French Monetary and Financial Code | | | | For | | For | |
| 9 | | Delegation of authority to the Board of directors to issue shares of the Company and/or other securites, without shareholders' preferential subscription right, for the benefit of a category of persons meeting certain characteristics | | | | For | | For | |
| 10 | | Delegation of authority to the Board of directors to issue shares of the Company and/or other securites, without shareholders' preferential subscription right, for the benefit of a category of persons meeting certain characteristics | | | | For | | For | |
| 11 | | Authorization of the Board of directors to increase the number of securities that may be issued as part of a share capital increase carried out pursuant to the delegations referred to in Proposal No. 6 to 10 above, with or without shareholders ' preferential subscription rights | | | | For | | For | |
| 12 | | Setting the overal limits on the amount of issues to be carried out pursuant to the delegations referred to in Proposal 6-11 above Propoal No. 21 below | | | | For | | For | |
| 13 | | Delegation of authority to the Board of directors to increase the share capital by incorporation of premiums, reserves, profits or other sums allowed to be capitalized | | | | For | | For | |
| 14 | | Delegation of authority to the Board of directors to grant existinf and/or newly issued free shares of the Company to all certain corporate officers of the Company of companies in the Group, in accordance with the provisions of aricles L. 225-197-1 et seq. of the French Commercial Code | | | | For | | For | |
| 15 | | Delegation of authority to the Board of directors to issue share warrants (bons de souscription d'actions), without shareholders' preferential subscription right, for the benefit of a category of persons meeting certain characteristics. | | | | For | | For | |
| 16 | | Delegation of authority to the Board of directors to grant options to subscribe for new ordinary shares or options to purchase ordinary shares of the Company, pirsuant to the provisions of articles L. 225-177 et seq. of the French Code, to all or certain employees and/or all or certain corporate officers of the Company or companies in the Group, in accordance with the provisions of articles L. 225-180 et seq. of the French Commerial Code | | | | For | | For | |
| 17 | | Delegation of authority to the Board of directors to increase the share capital by issuing ordinary share (in form of American Depository Shares ("ADSs")) of the Company, without shareholders ' prefential subscription right, for the benefit of a category of persons meeting certain characteristics under the 2021 Dynacure S.A. Employee Share Purchase Plan (the "ESPP") | | | | For | | For | |
| 18 | | Setting the overal limits on the amount of issues to be carried out pursuant to the delegations referred to in Proposal 6-11 above Proposals No. 14.15, 16 and 17 above | | | | For | | For | |
| 19 | | Delegation of authority to the Board of directors of the Company to increase the share capital by way of the issue of shares of the Company to participants in a company savings plan (plan d'epargne d'entreprise) established in accordance with articles L. 3332-1 et seq. of the French Labor Code | | | | For | | For | |
| 20 | | Delagation of the authority to the Board of directors to decide on any merger-absorption, split or partial asset contribution | | | | For | | For | |
| 21 | | Delegation of the authority to the Board of directors to increase the share capital by issuing ordinary shares, or any securities giving access to the Company's share capital, in the context of the merger absorption, split or partial asset contribution decided by the Board of directors pursuant to the twentieth resolution above | | | | For | | For | |
| 22 | | Authoritization to the Board of directors to reduce the Company's shares capital by canceling shares aquired by the Company | | | | For | | For | |
| 23 | | Delegation of authority to the Board of directors to reduce the share capital by way og buyback of Company shares followed by the cancellation of the repurchased shares | | | | For | | For | |
| 24 | | Ammendment of the article of 6 of the by-laws, subject to the non-retroactive condition precedent of the Form F-1 Effectiveness | | | | For | | For | |
| 25 | | Modification of the form of shares, subject to the non-retroactive precedent of F-1 Effectiveness | | | | For | | For | |
| 26 | | Modification of the form of shares, subject to the non-retroactive precedent of F-1 Effectiveness | | | | For | | For | |
| 27 | | Ammendment of article 13 of the above bylaws of the Company in order to extend the terms of office of the directors to three years, subject to the non-retroactive condition precedent of the Introduction | | | | For | | For | |
| 28 | | Adoption of the new bylaws, subject to the non-retroactive condition precedent of the Introduction | | | | For | | For | |
| 29 | | Powers to carry out formalities | | | | For | | For | |
EDWARDS LIFESCIENCES CORPORATION
| Security | 28176E108 | Meeting Type | Annual |
| Ticker Symbol | EW | Meeting Date | 04-May-2021 |
| Record Date | 10-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Election of Director: Kieran T. Gallahue | | Management | | For | | For | |
| 1.2 | | Election of Director: Leslie S. Heisz | | Management | | For | | For | |
| 1.3 | | Election of Director: Paul A. LaViolette | | Management | | For | | For | |
| 1.4 | | Election of Director: Steven R. Loranger | | Management | | For | | For | |
| 1.5 | | Election of Director: Martha H. Marsh | | Management | | For | | For | |
| 1.6 | | Election of Director: Michael A. Mussallem | | Management | | For | | For | |
| 1.7 | | Election of Director: Ramona Sequeira | | Management | | For | | For | |
| 1.8 | | Election of Director: Nicholas J. Valeriani | | Management | | For | | For | |
| 2. | | Advisory Vote to Approve Named Executive Officer Compensation. | | Management | | For | | For | |
| 3. | | Approval of the Amendment and Restatement of the Company's 2001 Employee Stock Purchase Plan for United States Employees (the "U.S. ESPP") to Increase the Total Number of Shares of Common Stock Available for Issuance under the U.S. ESPP by 3,300,000 Shares. | | Management | | For | | For | |
| 4. | | Approval of the Amendment and Restatement of the Company's 2001 Employee Stock Purchase Plan for International Employees (the "International ESPP") to Increase the Total Number of Shares of Common Stock Available for Issuance under the International ESPP by 1,200,000 Shares. | | Management | | For | | For | |
| 5. | | Ratification of Appointment of Independent Registered Public Accounting Firm. | | Management | | For | | For | |
| 6. | | Advisory Vote on a Stockholder Proposal Regarding Action by Written Consent. | | Shareholder | | Against | | For | |
| 7. | | Advisory Vote on a Stockholder Proposal to Adopt a Policy to Include Non-Management Employees as Prospective Director Candidates. | | Shareholder | | Against | | For | |
EISAI CO.,LTD.
| Security | J12852117 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 18-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1.1 | | Appoint a Director Naito, Haruo | | Management | | For | | For | |
| 1.2 | | Appoint a Director Kato, Yasuhiko | | Management | | For | | For | |
| 1.3 | | Appoint a Director Bruce Aronson | | Management | | For | | For | |
| 1.4 | | Appoint a Director Tsuchiya, Yutaka | | Management | | For | | For | |
| 1.5 | | Appoint a Director Kaihori, Shuzo | | Management | | For | | For | |
| 1.6 | | Appoint a Director Murata, Ryuichi | | Management | | For | | For | |
| 1.7 | | Appoint a Director Uchiyama, Hideyo | | Management | | For | | For | |
| 1.8 | | Appoint a Director Hayashi, Hideki | | Management | | For | | For | |
| 1.9 | | Appoint a Director Miwa, Yumiko | | Management | | For | | For | |
| 1.10 | | Appoint a Director Ike, Fumihiko | | Management | | For | | For | |
| 1.11 | | Appoint a Director Kato, Yoshiteru | | Management | | For | | For | |
| 1.12 | | Appoint a Director Miura, Ryota | | Management | | For | | For | |
ELI LILLY AND COMPANY
| Security | 532457108 | Meeting Type | Annual |
| Ticker Symbol | LLY | Meeting Date | 03-May-2021 |
| Record Date | 22-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1a. | | Election of Director to serve a three year term: K. Baicker, Ph.D. | | Management | | For | | For | |
| 1b. | | Election of Director to serve a three year term: J.E. Fyrwald | | Management | | For | | For | |
| 1c. | | Election of Director to serve a three year term: J. Jackson | | Management | | For | | For | |
| 1d. | | Election of Director to serve a three year term: G. Sulzberger | | Management | | For | | For | |
| 1e. | | Election of Director to serve a three year term: J.P. Tai | | Management | | For | | For | |
| 2. | | Approval, on an advisory basis, of the compensation paid to the company's named executive officers. | | Management | | For | | For | |
| 3. | | Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2021. | | Management | | For | | For | |
| 4. | | Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure. | | Management | | For | | For | |
| 5. | | Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions. | | Management | | For | | For | |
| 6. | | Shareholder proposal to disclose direct and indirect lobbying activities and expenditures. | | Shareholder | | Against | | For | |
| 7. | | Shareholder proposal to amend the bylaws to require an independent board chair. | | Shareholder | | For | | Against | |
| 8. | | Shareholder proposal to implement a bonus deferral policy. | | Shareholder | | Against | | For | |
| 9. | | Shareholder proposal to disclose clawbacks on executive incentive compensation due to misconduct. | | Shareholder | | Against | | For | |
ENDO INTERNATIONAL PLC
| Security | G30401106 | Meeting Type | Annual |
| Ticker Symbol | ENDP | Meeting Date | 10-Jun-2021 |
| Record Date | 12-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director to serve until the next Annual General Meeting of the Shareholders: Mark G. Barberio | | Management | | For | | For | |
| 1B. | | Election of Director to serve until the next Annual General Meeting of the Shareholders: Jennifer M. Chao | | Management | | For | | For | |
| 1C. | | Election of Director to serve until the next Annual General Meeting of the Shareholders: Blaise Coleman | | Management | | For | | For | |
| 1D. | | Election of Director to serve until the next Annual General Meeting of the Shareholders: Shane M. Cooke | | Management | | For | | For | |
| 1E. | | Election of Director to serve until the next Annual General Meeting of the Shareholders: Nancy J. Hutson, Ph.D. | | Management | | For | | For | |
| 1F. | | Election of Director to serve until the next Annual General Meeting of the Shareholders: Michael Hyatt | | Management | | For | | For | |
| 1G. | | Election of Director to serve until the next Annual General Meeting of the Shareholders: William P. Montague | | Management | | For | | For | |
| 1H. | | Election of Director to serve until the next Annual General Meeting of the Shareholders: M. Christine Smith, Ph.D. | | Management | | For | | For | |
| 2. | | To approve, by advisory vote, named executive officer compensation. | | Management | | For | | For | |
| 3. | | To renew the Board's existing authority to issue shares under Irish law. | | Management | | For | | For | |
| 4. | | To renew the Board's existing authority to opt-out of statutory pre-emption rights under Irish law. | | Management | | For | | For | |
| 5. | | To approve the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2021 and to authorize the Board of Directors, acting through the Audit & Finance Committee, to determine the independent registered public accounting firm's remuneration. | | Management | | For | | For | |
EVEREST MEDICINES LIMITED
| Security | G3224E106 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 01-Jun-2021 |
| Record Date | 26-May-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | TO RECEIVE AND ADOPT THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE YEAR ENDED 31 DECEMBER 2020 AND THE REPORTS OF THE DIRECTORS AND THE AUDITOR INDEPENDENT AUDITOR THEREON | | Management | | For | | For | |
| 2.A | | TO RE-ELECT MR. WEI FU AS AN EXECUTIVE DIRECTOR | | Management | | For | | For | |
| 2.B | | TO RE-ELECT MR. IAN YING WOO AS AN EXECUTIVE DIRECTOR | | Management | | For | | For | |
| 2.C | | TO RE-ELECT MR. XIAOFAN ZHANG AS AN EXECUTIVE DIRECTOR | | Management | | For | | For | |
| 2.D | | TO RE-ELECT MS. LAN KANG AS A NON-EXECUTIVE DIRECTOR | | Management | | For | | For | |
| 2.E | | TO AUTHORIZE THE BOARD OF DIRECTORS (THE "BOARD") TO FIX THE REMUNERATION OF THE DIRECTORS | | Management | | For | | For | |
| 3 | | TO RE-APPOINT PRICEWATERHOUSECOOPERS AS THE AUDITOR AND TO AUTHORIZE THE BOARD TO FIX THEIR REMUNERATION | | Management | | For | | For | |
| 4 | | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO REPURCHASE SHARES OF THE COMPANY NOT EXCEEDING 10% OF THE TOTAL NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF PASSING OF THIS RESOLUTION | | Management | | For | | For | |
| 5 | | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF PASSING OF THIS RESOLUTION | | Management | | For | | For | |
| 6 | | TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES IN THE CAPITAL OF THE COMPANY BY THE AGGREGATE NUMBER OF THE SHARES REPURCHASED BY THE COMPANY | | Management | | For | | For | |
EXACT SCIENCES CORPORATION
| Security | 30063P105 | Meeting Type | Annual |
| Ticker Symbol | EXAS | Meeting Date | 30-Jun-2021 |
| Record Date | 06-May-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Paul Clancy | | | | For | | For | |
| | | 2 | Pierre Jacquet | | | | For | | For | |
| | | 3 | Daniel Levangie | | | | For | | For | |
| 2. | | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2021. | | Management | | For | | For | |
| 3. | | To approve, on an advisory basis, the compensation of the Company's named executive officers. | | Management | | For | | For | |
FIVE STAR SENIOR LIVING INC.
| Security | 33832D205 | Meeting Type | Annual |
| Ticker Symbol | FVE | Meeting Date | 08-Jun-2021 |
| Record Date | 24-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director (for Independent Director in Group II): Donna D. Fraiche | | Management | | For | | For | |
| 1B. | | Election of Director (for Independent Director in Group II): Gerard M. Martin | | Management | | For | | For | |
| 2. | | Ratification of the appointment of RSM US LLP as independent auditors to serve for the 2021 fiscal year. | | Management | | For | | For | |
GALERA THERAPEUTICS, INC.
| Security | 36338D108 | Meeting Type | Annual |
| Ticker Symbol | GRTX | Meeting Date | 16-Jun-2021 |
| Record Date | 23-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Lawrence Alleva | | | | For | | For | |
| | | 2 | Kevin Lokay | | | | For | | For | |
| 2. | | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
GILEAD SCIENCES, INC.
| Security | 375558103 | Meeting Type | Annual |
| Ticker Symbol | GILD | Meeting Date | 12-May-2021 |
| Record Date | 19-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director to serve for the next year: Jacqueline K. Barton, Ph.D. | | Management | | For | | For | |
| 1B. | | Election of Director to serve for the next year: Jeffrey A. Bluestone, Ph.D. | | Management | | For | | For | |
| 1C. | | Election of Director to serve for the next year: Sandra J. Horning, M.D. | | Management | | For | | For | |
| 1D. | | Election of Director to serve for the next year: Kelly A. Kramer | | Management | | For | | For | |
| 1E. | | Election of Director to serve for the next year: Kevin E. Lofton | | Management | | For | | For | |
| 1F. | | Election of Director to serve for the next year: Harish Manwani | | Management | | For | | For | |
| 1G. | | Election of Director to serve for the next year: Daniel P. O'Day | | Management | | For | | For | |
| 1H. | | Election of Director to serve for the next year: Javier J. Rodriguez | | Management | | For | | For | |
| 1I. | | Election of Director to serve for the next year: Anthony Welters | | Management | | For | | For | |
| 2. | | To ratify the selection of Ernst & Young LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. | | Management | | For | | For | |
| 4. | | To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director. | | Shareholder | | Against | | For | |
GLOBAL MEDICAL REIT INC.
| Security | 37954A204 | Meeting Type | Annual |
| Ticker Symbol | GMRE | Meeting Date | 02-Sep-2020 |
| Record Date | 13-Jul-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Election of Director: Jeffrey M. Busch | | Management | | For | | For | |
| 1.2 | | Election of Director: Matthew Cypher | | Management | | For | | For | |
| 1.3 | | Election of Director: Zhang Jingguo | | Management | | For | | For | |
| 1.4 | | Election of Director: Ronald Marston | | Management | | For | | For | |
| 1.5 | | Election of Director: Roscoe Moore, Jr. | | Management | | For | | For | |
| 1.6 | | Election of Director: Henry E. Cole | | Management | | For | | For | |
| 1.7 | | Election of Director: Zhang Huiqi | | Management | | For | | For | |
| 1.8 | | Election of Director: Paula R. Crowley | | Management | | For | | For | |
| 1.9 | | Election of Director: Lori Wittman | | Management | | For | | For | |
| 2. | | Advisory vote to approve the compensation of the Company's named executive officers as described in the accompanying Proxy Statement. | | Management | | For | | For | |
| 3. | | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2020. | | Management | | For | | For | |
GLOBAL MEDICAL REIT INC.
| Security | 37954A204 | Meeting Type | Annual |
| Ticker Symbol | GMRE | Meeting Date | 26-May-2021 |
| Record Date | 01-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Election of Director: Jeffrey M. Busch | | Management | | For | | For | |
| 1.2 | | Election of Director: Matthew Cypher | | Management | | For | | For | |
| 1.3 | | Election of Director: Ronald Marston | | Management | | For | | For | |
| 1.4 | | Election of Director: Roscoe Moore, Jr. | | Management | | For | | For | |
| 1.5 | | Election of Director: Henry E. Cole | | Management | | For | | For | |
| 1.6 | | Election of Director: Zhang Huiqi | | Management | | For | | For | |
| 1.7 | | Election of Director: Paula R. Crowley | | Management | | For | | For | |
| 1.8 | | Election of Director: Lori Wittman | | Management | | For | | For | |
| 2. | | Advisory vote to approve the compensation of the Company's named executive officers as described in the accompanying Proxy Statement. | | Management | | For | | For | |
| 3. | | To approve an amendment to the Company's 2016 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,500,000. | | Management | | For | | For | |
| 4. | | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2021. | | Management | | For | | For | |
HCA HEALTHCARE, INC.
| Security | 40412C101 | Meeting Type | Annual |
| Ticker Symbol | HCA | Meeting Date | 28-Apr-2021 |
| Record Date | 08-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Thomas F. Frist III | | Management | | For | | For | |
| 1B. | | Election of Director: Samuel N. Hazen | | Management | | For | | For | |
| 1C. | | Election of Director: Meg G. Crofton | | Management | | For | | For | |
| 1D. | | Election of Director: Robert J. Dennis | | Management | | For | | For | |
| 1E. | | Election of Director: Nancy-Ann DeParle | | Management | | For | | For | |
| 1F. | | Election of Director: William R. Frist | | Management | | For | | For | |
| 1G. | | Election of Director: Charles O. Holliday, Jr | | Management | | For | | For | |
| 1H. | | Election of Director: Michael W. Michelson | | Management | | For | | For | |
| 1I. | | Election of Director: Wayne J. Riley, M.D. | | Management | | For | | For | |
| 2. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
| 4. | | Stockholder proposal, if properly presented at the meeting, requesting that the Board of Directors take the steps necessary to allow stockholders to act by written consent. | | Shareholder | | Against | | For | |
| 5. | | Stockholder proposal, if properly presented at the meeting, requesting a report on the feasibility of increasing the impact of quality metrics on executive compensation. | | Shareholder | | Against | | For | |
HEALTHCARE REALTY TRUST INCORPORATED
| Security | 421946104 | Meeting Type | Annual |
| Ticker Symbol | HR | Meeting Date | 11-May-2021 |
| Record Date | 12-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Todd J. Meredith | | | | For | | For | |
| | | 2 | John V. Abbott | | | | For | | For | |
| | | 3 | Nancy H. Agee | | | | For | | For | |
| | | 4 | Edward H. Braman | | | | For | | For | |
| | | 5 | Ajay Gupta | | | | For | | For | |
| | | 6 | James J. Kilroy | | | | For | | For | |
| | | 7 | Peter F. Lyle, Sr. | | | | For | | For | |
| | | 8 | John Knox Singleton | | | | For | | For | |
| | | 9 | Christann M. Vasquez | | | | For | | For | |
| 2. | | To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2021 fiscal year. | | Management | | For | | For | |
| 3. | | To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the shareholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2021 Annual Meeting of Shareholders. | | Management | | For | | For | |
HEALTHCARE TRUST OF AMERICA, INC.
| Security | 42225P501 | Meeting Type | Annual |
| Ticker Symbol | HTA | Meeting Date | 07-Jul-2020 |
| Record Date | 15-Apr-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Scott D. Peters | | Management | | For | | For | |
| 1B. | | Election of Director: W. Bradley Blair, II | | Management | | For | | For | |
| 1C. | | Election of Director: Vicki U. Booth | | Management | | For | | For | |
| 1D. | | Election of Director: H. Lee Cooper | | Management | | For | | For | |
| 1E. | | Election of Director: Warren D. Fix | | Management | | For | | For | |
| 1F. | | Election of Director: Peter N. Foss | | Management | | For | | For | |
| 1G. | | Election of Director: Jay P. Leupp | | Management | | For | | For | |
| 1H. | | Election of Director: Gary T. Wescombe | | Management | | For | | For | |
| 2. | | To approve, on an advisory vote, the compensation of our named executive officers. | | Management | | For | | For | |
| 3. | | To consider and vote upon the ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2020. | | Management | | For | | For | |
HEALTHPEAK PROPERTIES, INC
| Security | 42250P103 | Meeting Type | Annual |
| Ticker Symbol | PEAK | Meeting Date | 28-Apr-2021 |
| Record Date | 01-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Brian G. Cartwright | | Management | | For | | For | |
| 1B. | | Election of Director: Christine N. Garvey | | Management | | For | | For | |
| 1C. | | Election of Director: R. Kent Griffin, Jr. | | Management | | For | | For | |
| 1D. | | Election of Director: David B. Henry | | Management | | For | | For | |
| 1E. | | Election of Director: Thomas M. Herzog | | Management | | For | | For | |
| 1F. | | Election of Director: Lydia H. Kennard | | Management | | For | | For | |
| 1G. | | Election of Director: Sara G. Lewis | | Management | | For | | For | |
| 1H. | | Election of Director: Katherine M. Sandstrom | | Management | | For | | For | |
| 2. | | Approval of 2020 executive compensation on an advisory basis. | | Management | | For | | For | |
| 3. | | Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2021. | | Management | | For | | For | |
HOLOGIC, INC.
| Security | 436440101 | Meeting Type | Annual |
| Ticker Symbol | HOLX | Meeting Date | 11-Mar-2021 |
| Record Date | 12-Jan-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Stephen P. MacMillan | | Management | | For | | For | |
| 1B. | | Election of Director: Sally W. Crawford | | Management | | For | | For | |
| 1C. | | Election of Director: Charles J. Dockendorff | | Management | | For | | For | |
| 1D. | | Election of Director: Scott T. Garrett | | Management | | For | | For | |
| 1E. | | Election of Director: Ludwig N. Hantson | | Management | | For | | For | |
| 1F. | | Election of Director: Namal Nawana | | Management | | For | | For | |
| 1G. | | Election of Director: Christiana Stamoulis | | Management | | For | | For | |
| 1H. | | Election of Director: Amy M. Wendell | | Management | | For | | For | |
| 2. | | A non-binding advisory resolution to approve executive compensation. | | Management | | For | | For | |
| 3. | | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2021. | | Management | | For | | For | |
HORIZON THERAPEUTICS PLC
| Security | G46188101 | Meeting Type | Annual |
| Ticker Symbol | HZNP | Meeting Date | 29-Apr-2021 |
| Record Date | 24-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Class I Director: William F. Daniel | | Management | | For | | For | |
| 1B. | | Election of Class I Director: H. Thomas Watkins | | Management | | For | | For | |
| 1C. | | Election of Class I Director: Pascale Witz | | Management | | For | | For | |
| 2. | | Approval of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021 and authorization of the Audit Committee to determine the auditors' remuneration. | | Management | | For | | For | |
| 3. | | Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy Statement. | | Management | | For | | For | |
| 4. | | Authorization for us and/or any of our subsidiaries to make market purchases or overseas market purchases of our ordinary shares. | | Management | | For | | For | |
| 5. | | Approval of the Amended and Restated 2020 Equity Incentive Plan. | | Management | | For | | For | |
HOYA CORPORATION
| Security | J22848105 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 29-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1.1 | | Appoint a Director Uchinaga, Yukako | | Management | | For | | For | |
| 1.2 | | Appoint a Director Urano, Mitsudo | | Management | | For | | For | |
| 1.3 | | Appoint a Director Kaihori, Shuzo | | Management | | For | | For | |
| 1.4 | | Appoint a Director Yoshihara, Hiroaki | | Management | | For | | For | |
| 1.5 | | Appoint a Director Abe, Yasuyuki | | Management | | For | | For | |
| 1.6 | | Appoint a Director Suzuki, Hiroshi | | Management | | For | | For | |
HUMANA INC.
| Security | 444859102 | Meeting Type | Annual |
| Ticker Symbol | HUM | Meeting Date | 22-Apr-2021 |
| Record Date | 22-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A) | | Election of Director: Kurt J. Hilzinger | | Management | | For | | For | |
| 1B) | | Election of Director: Raquel C. Bono, M.D. | | Management | | For | | For | |
| 1C) | | Election of Director: Bruce D. Broussard | | Management | | For | | For | |
| 1D) | | Election of Director: Frank A. D'Amelio | | Management | | For | | For | �� |
| 1E) | | Election of Director: Wayne A. I. Frederick, M.D. | | Management | | For | | For | |
| 1F) | | Election of Director: John W. Garratt | | Management | | For | | For | |
| 1G) | | Election of Director: David A. Jones, Jr. | | Management | | For | | For | |
| 1H) | | Election of Director: Karen W. Katz | | Management | | For | | For | |
| 1I) | | Election of Director: Marcy S. Klevorn | | Management | | For | | For | |
| 1J) | | Election of Director: William J. McDonald | | Management | | For | | For | |
| 1K) | | Election of Director: Jorge S. Mesquita | | Management | | For | | For | |
| 1L) | | Election of Director: James J. O'Brien | | Management | | For | | For | |
| 1M) | | Election of Director: Marissa T. Peterson | | Management | | For | | For | |
| 2. | | The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. | | Management | | For | | For | |
| 3. | | Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2021 proxy statement. | | Management | | For | | For | |
ICON PLC
| Security | G4705A100 | Meeting Type | Special |
| Ticker Symbol | ICLR | Meeting Date | 15-Jun-2021 |
| Record Date | 26-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | The proposal to approve the issuance of ICON ordinary shares to PRA stockholders pursuant to the merger agreement, which is referred to as the ICON share issuance proposal. | | Management | | For | | For | |
| 2. | | The proposal to adjourn the ICON EGM to solicit additional proxies if there are not sufficient votes to approve the ICON share issuance proposal, which is referred to as the ICON adjournment proposal. | | Management | | For | | For | |
IDEXX LABORATORIES, INC.
| Security | 45168D104 | Meeting Type | Annual |
| Ticker Symbol | IDXX | Meeting Date | 12-May-2021 |
| Record Date | 19-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Bruce L. Claflin | | Management | | For | | For | |
| 1B. | | Election of Director: Asha S. Collins, PhD | | Management | | For | | For | |
| 1C. | | Election of Director: Daniel M. Junius | | Management | | For | | For | |
| 1D. | | Election of Director: Sam Samad | | Management | | For | | For | |
| 2. | | Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). | | Management | | For | | For | |
| 3. | | Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). | | Management | | For | | For | |
ILLUMINA, INC.
| Security | 452327109 | Meeting Type | Annual |
| Ticker Symbol | ILMN | Meeting Date | 26-May-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Caroline D. Dorsa | | Management | | For | | For | |
| 1B. | | Election of Director: Robert S. Epstein, M.D. | | Management | | For | | For | |
| 1C. | | Election of Director: Scott Gottlieb, M.D. | | Management | | For | | For | |
| 1D. | | Election of Director: Gary S. Guthart | | Management | | For | | For | |
| 1E. | | Election of Director: Philip W. Schiller | | Management | | For | | For | |
| 1F. | | Election of Director: John W. Thompson | | Management | | For | | For | |
| 2. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 2, 2022. | | Management | | For | | For | |
| 3. | | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | | Management | | For | | For | |
INCYTE CORPORATION
| Security | 45337C102 | Meeting Type | Annual |
| Ticker Symbol | INCY | Meeting Date | 26-May-2021 |
| Record Date | 29-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Election of Director: Julian C. Baker | | Management | | For | | For | |
| 1.2 | | Election of Director: Jean-Jacques Bienaimé | | Management | | For | | For | |
| 1.3 | | Election of Director: Paul J. Clancy | | Management | | For | | For | |
| 1.4 | | Election of Director: Wendy L. Dixon | | Management | | For | | For | |
| 1.5 | | Election of Director: Jacqualyn A. Fouse | | Management | | For | | For | |
| 1.6 | | Election of Director: Edmund P. Harrigan | | Management | | For | | For | |
| 1.7 | | Election of Director: Katherine A. High | | Management | | For | | For | |
| 1.8 | | Election of Director: Hervé Hoppenot | | Management | | For | | For | |
| 2. | | Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | | Management | | For | | For | |
| 3. | | Approve amendments to the Company's Amended and Restated 2010 Stock Incentive Plan. | | Management | | For | | For | |
| 4. | | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2021. | | Management | | For | | For | |
INTUITIVE SURGICAL, INC.
| Security | 46120E602 | Meeting Type | Annual |
| Ticker Symbol | ISRG | Meeting Date | 22-Apr-2021 |
| Record Date | 05-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Craig H. Barratt, Ph.D. | | Management | | For | | For | |
| 1B. | | Election of Director: Joseph C. Beery | | Management | | For | | For | |
| 1C. | | Election of Director: Gary S. Guthart, Ph.D. | | Management | | For | | For | |
| 1D. | | Election of Director: Amal M. Johnson | | Management | | For | | For | |
| 1E. | | Election of Director: Don R. Kania, Ph.D. | | Management | | For | | For | |
| 1F. | | Election of Director: Amy L. Ladd, M.D. | | Management | | For | | For | |
| 1G. | | Election of Director: Keith R. Leonard, Jr. | | Management | | For | | For | |
| 1H. | | Election of Director: Alan J. Levy, Ph.D. | | Management | | For | | For | |
| 1I. | | Election of Director: Jami Dover Nachtsheim | | Management | | For | | For | |
| 1J. | | Election of Director: Monica P. Reed, M.D. | | Management | | For | | For | |
| 1K. | | Election of Director: Mark J. Rubash | | Management | | For | | For | |
| 2. | | To approve, by advisory vote, the compensation of the Company's Named Executive Officers. | | Management | | For | | For | |
| 3. | | The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 4. | | To approve the Company's Amended and Restated 2010 Incentive Award Plan. | | Management | | For | | For | |
IOVANCE BIOTHERAPEUTICS, INC.
| Security | 462260100 | Meeting Type | Annual |
| Ticker Symbol | IOVA | Meeting Date | 11-Jun-2021 |
| Record Date | 19-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Iain Dukes, D. Phil | | | | For | | For | |
| | | 2 | Maria Fardis, Ph.D, MBA | | | | For | | For | |
| | | 3 | Athena Countouriotis MD | | | | For | | For | |
| | | 4 | Ryan Maynard | | | | For | | For | |
| | | 5 | Merrill A. McPeak | | | | For | | For | |
| | | 6 | Wayne P. Rothbaum | | | | For | | For | |
| | | 7 | Michael Weiser MD Ph.D | | | | For | | For | |
| 2. | | To approve, by non-binding advisory vote, the compensation of our named executive officers. | | Management | | For | | For | |
| 3. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021. | | Management | | For | | For | |
IQVIA HOLDINGS INC.
| Security | 46266C105 | Meeting Type | Annual |
| Ticker Symbol | IQV | Meeting Date | 13-Apr-2021 |
| Record Date | 12-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Ari Bousbib | | | | For | | For | |
| | | 2 | John M. Leonard M.D. | | | | For | | For | |
| | | 3 | Todd B. Sisitsky | | | | For | | For | |
| 2. | | RECOMMEND, IN AN ADVISORY (NON-BINDING) VOTE, THE FREQUENCY OF THE ADVISORY VOTE ON EXECUTIVE COMPENSATION. | | Management | | 1 Year | | | |
| 3A. | | AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO REMOVE SUPERMAJORITY VOTING STANDARD FOR STOCKHOLDER APPROVAL OF FUTURE AMENDMENTS, ALTERATIONS, CHANGES OR REPEAL OF THE BYLAWS. | | Management | | For | | For | |
| 3B. | | AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO REMOVE SUPERMAJORITY VOTING STANDARD TO REMOVE, FOR CAUSE ONLY, A DIRECTOR OR THE ENTIRE BOARD. | | Management | | For | | For | |
| 4. | | THE RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS IQVIA HOLDINGS INC.'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2021. | | Management | | For | | For | |
JOHNSON & JOHNSON
| Security | 478160104 | Meeting Type | Annual |
| Ticker Symbol | JNJ | Meeting Date | 22-Apr-2021 |
| Record Date | 23-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Mary C. Beckerle | | Management | | For | | For | |
| 1B. | | Election of Director: D. Scott Davis | | Management | | For | | For | |
| 1C. | | Election of Director: Ian E. L. Davis | | Management | | For | | For | |
| 1D. | | Election of Director: Jennifer A. Doudna | | Management | | For | | For | |
| 1E. | | Election of Director: Alex Gorsky | | Management | | For | | For | |
| 1F. | | Election of Director: Marillyn A. Hewson | | Management | | For | | For | |
| 1G. | | Election of Director: Hubert Joly | | Management | | For | | For | |
| 1H. | | Election of Director: Mark B. McClellan | | Management | | For | | For | |
| 1I. | | Election of Director: Anne M. Mulcahy | | Management | | For | | For | |
| 1J. | | Election of Director: Charles Prince | | Management | | For | | For | |
| 1K. | | Election of Director: A. Eugene Washington | | Management | | For | | For | |
| 1L. | | Election of Director: Mark A. Weinberger | | Management | | For | | For | |
| 1M. | | Election of Director: Nadja Y. West | | Management | | For | | For | |
| 1N. | | Election of Director: Ronald A. Williams | | Management | | For | | For | |
| 2. | | Advisory Vote to Approve Named Executive Officer Compensation. | | Management | | For | | For | |
| 3. | | Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2021. | | Management | | For | | For | |
| 4. | | Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics. | | Shareholder | | Against | | For | |
| 5. | | Independent Board Chair. | | Shareholder | | For | | Against | |
| 6. | | Civil Rights Audit. | | Shareholder | | Against | | For | |
| 7. | | Executive Compensation Bonus Deferral. | | Shareholder | | Against | | For | |
KONINKLIJKE PHILIPS ELECTRONICS N.V.
| Security | 500472303 | Meeting Type | Annual |
| Ticker Symbol | PHG | Meeting Date | 06-May-2021 |
| Record Date | 08-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 2B. | | Annual Report 2020: Proposal to adopt the financial statements. | | Management | | For | | | |
| 2C. | | Annual Report 2020: Proposal to adopt dividend | | Management | | For | | | |
| 2D. | | Annual Report 2020: Advisory vote on the Remuneration Report 2020. | | Management | | For | | | |
| 2E. | | Annual Report 2020: Proposal to discharge the members of the Board of Management. | | Management | | For | | | |
| 2F. | | Annual Report 2020: Proposal to discharge the members of the Supervisory Board. | | Management | | For | | | |
| 3. | | Composition of the Board of Management: Proposal to re-appoint Mr M.J. van Ginneken as member of the Board of Management. | | Management | | For | | | |
| 4A. | | Composition of the Supervisory Board: Proposal to appoint Mrs S.K. Chua as member of the Supervisory Board. | | Management | | For | | | |
| 4B. | | Composition of the Supervisory Board: Proposal to appoint Mrs I.K. Nooyi as member of the Supervisory Board. | | Management | | For | | | |
| 5A. | | To authorize the Board of Management to: issue shares or grant rights to acquire shares. | | Management | | For | | | |
| 5B. | | To authorize the Board of Management to: restrict or exclude pre-emption rights. | | Management | | For | | | |
| 6. | | Proposal to authorize the Board of Management to acquire shares in the company. | | Management | | For | | | |
| 7. | | Proposal to cancel shares. | | Management | | For | | | |
LABORATORY CORP. OF AMERICA HOLDINGS
| Security | 50540R409 | Meeting Type | Annual |
| Ticker Symbol | LH | Meeting Date | 12-May-2021 |
| Record Date | 24-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Kerrii B. Anderson | | Management | | For | | For | |
| 1B. | | Election of Director: Jean-Luc Bélingard | | Management | | For | | For | |
| 1C. | | Election of Director: Jeffrey A. Davis | | Management | | For | | For | |
| 1D. | | Election of Director: D. Gary Gilliland, M.D., Ph.D. | | Management | | For | | For | |
| 1E. | | Election of Director: Garheng Kong, M.D., Ph.D. | | Management | | For | | For | |
| 1F. | | Election of Director: Peter M. Neupert | | Management | | For | | For | |
| 1G. | | Election of Director: Richelle P. Parham | | Management | | For | | For | |
| 1H. | | Election of Director: Adam H. Schechter | | Management | | For | | For | |
| 1I. | | Election of Director: Kathryn E. Wengel | | Management | | For | | For | |
| 1J. | | Election of Director: R. Sanders Williams, M.D. | | Management | | For | | For | |
| 2. | | To approve, by non-binding vote, executive compensation. | | Management | | For | | For | |
| 3. | | Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2021. | | Management | | For | | For | |
| 4. | | Shareholder proposal seeking an amendment to our proxy access by-law to remove the aggregation limit. | | Shareholder | | Against | | For | |
LONZA GROUP AG
| Security | H50524133 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 06-May-2021 |
| Record Date | 22-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | ANNUAL REPORT, CONSOLIDATED FINANCIAL STATEMENTS AND FINANCIAL STATEMENTS OF LONZA | | Management | | Abstain | | Against | |
| 2 | | CONSULTATIVE VOTE ON THE REMUNERATION REPORT | | Management | | Abstain | | Against | |
| 3 | | DISCHARGE OF THE MEMBERS OF THE BOARD OF DIRECTORS AND THE EXECUTIVE COMMITTEE | | Management | | Abstain | | Against | |
| 4 | | APPROPRIATION OF AVAILABLE EARNINGS / RESERVES FROM CAPITAL CONTRIBUTION: CHF 3.00 PER SHARE | | Management | | Abstain | | Against | |
| 5.1.A | | RE-ELECTION TO THE BOARD OF DIRECTORS: WERNER BAUER | | Management | | Abstain | | Against | |
| 5.1.B | | RE-ELECTION TO THE BOARD OF DIRECTORS: ALBERT M. BAEHNY | | Management | | Abstain | | Against | |
| 5.1.C | | RE-ELECTION TO THE BOARD OF DIRECTORS: DOROTHEE DEURING | | Management | | Abstain | | Against | |
| 5.1.D | | RE-ELECTION TO THE BOARD OF DIRECTORS: ANGELICA KOHLMANN | | Management | | Abstain | | Against | |
| 5.1.E | | RE-ELECTION TO THE BOARD OF DIRECTORS: CHRISTOPH MADER | | Management | | Abstain | | Against | |
| 5.1.F | | RE-ELECTION TO THE BOARD OF DIRECTORS: BARBARA RICHMOND | | Management | | Abstain | | Against | |
| 5.1.G | | RE-ELECTION TO THE BOARD OF DIRECTORS: JURGEN STEINEMANN | | Management | | Abstain | | Against | |
| 5.1.H | | RE-ELECTION TO THE BOARD OF DIRECTORS: OLIVIER VERSCHEURE | | Management | | Abstain | | Against | |
| 5.2 | | RE-ELECTION OF ALBERT M. BAEHNY AS CHAIRMAN OF THE BOARD OF DIRECTORS | | Management | | Abstain | | Against | |
| 5.3.A | | RE-ELECTION TO THE NOMINATION AND COMPENSATION COMMITTEE: ANGELICA KOHLMANN | | Management | | Abstain | | Against | |
| 5.3.B | | RE-ELECTION TO THE NOMINATION AND COMPENSATION COMMITTEE: CHRISTOPH MADER | | Management | | Abstain | | Against | |
| 5.3.C | | RE-ELECTION TO THE NOMINATION AND COMPENSATION COMMITTEE: JURGEN STEINEMANN | | Management | | Abstain | | Against | |
| 6 | | RE-ELECTION OF KPMG LTD, ZURICH AS AUDITORS | | Management | | Abstain | | Against | |
| 7 | | RE-ELECTION OF THOMANNFISCHER, BASEL AS INDEPENDENT PROXY | | Management | | Abstain | | Against | |
| 8 | | COMPENSATION OF THE BOARD OF DIRECTORS | | Management | | Abstain | | Against | |
| 9.1 | | COMPENSATION OF THE EXECUTIVE COMMITTEE: MAXIMUM AGGREGATE AMOUNT OF FIXED COMPENSATION OF THE EXECUTIVE COMMITTEE | | Management | | Abstain | | Against | |
| 9.2 | | COMPENSATION OF THE EXECUTIVE COMMITTEE: AGGREGATE AMOUNT OF VARIABLE SHORT-TERM COMPENSATION OF THE EXECUTIVE COMMITTEE | | Management | | Abstain | | Against | |
| 9.3 | | COMPENSATION OF THE EXECUTIVE COMMITTEE: MAXIMUM AGGREGATE AMOUNT OF VARIABLE LONG-TERM COMPENSATION OF THE EXECUTIVE COMMITTEE | | Management | | Abstain | | Against | |
| 10 | | RENEWAL OF AUTHORIZED CAPITAL | | Management | | Abstain | | Against | |
| 11 | | IN THE EVENT OF ANY YET UNKNOWN NEW OR MODIFIED PROPOSAL BY A SHAREHOLDER DURING THE ANNUAL GENERAL MEETING, I INSTRUCT THE INDEPENDENT REPRESENTATIVE TO VOTE AS FOLLOWS (YES = VOTE IN FAVOR OF ANY SUCH YET UNKONWN PROPOSAL; NO = VOTE AGAINST ANY SUCH YET UNKNOWN PORPOSAL; ABSTAIN) | | Shareholder | | Abstain | | Against | |
LTC PROPERTIES, INC.
| Security | 502175102 | Meeting Type | Annual |
| Ticker Symbol | LTC | Meeting Date | 26-May-2021 |
| Record Date | 12-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director to hold office until the 2022 Annual Meeting: Cornelia Cheng | | Management | | For | | For | |
| 1B. | | Election of Director to hold office until the 2022 Annual Meeting: Boyd W. Hendrickson | | Management | | For | | For | |
| 1C. | | Election of Director to hold office until the 2022 Annual Meeting: James J. Pieczynski | | Management | | For | | For | |
| 1D. | | Election of Director to hold office until the 2022 Annual Meeting: Devra G. Shapiro | | Management | | For | | For | |
| 1E. | | Election of Director to hold office until the 2022 Annual Meeting: Wendy L. Simpson | | Management | | For | | For | |
| 1F. | | Election of Director to hold office until the 2022 Annual Meeting: Timothy J. Triche | | Management | | For | | For | |
| 2. | | Approval of the 2021 Equity Participation Plan. | | Management | | For | | For | |
| 3. | | Ratification of independent registered public accounting firm. | | Management | | For | | For | |
| 4. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
M3, INC.
| Security | J4697J108 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 25-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Appoint a Director who is not Audit and Supervisory Committee Member Tanimura, Itaru | | Management | | For | | For | |
| 1.2 | | Appoint a Director who is not Audit and Supervisory Committee Member Tomaru, Akihiko | | Management | | For | | For | |
| 1.3 | | Appoint a Director who is not Audit and Supervisory Committee Member Tsuchiya, Eiji | | Management | | For | | For | |
| 1.4 | | Appoint a Director who is not Audit and Supervisory Committee Member Izumiya, Kazuyuki | | Management | | For | | For | |
| 1.5 | | Appoint a Director who is not Audit and Supervisory Committee Member Urae, Akinori | | Management | | For | | For | |
| 1.6 | | Appoint a Director who is not Audit and Supervisory Committee Member Yoshida, Kenichiro | | Management | | For | | For | |
| 2 | | Approve Details of Compensation as Stock Options for Directors (Excluding Directors who are Audit and Supervisory Committee Members) | | Management | | For | | For | |
MCKESSON CORPORATION
| Security | 58155Q103 | Meeting Type | Annual |
| Ticker Symbol | MCK | Meeting Date | 29-Jul-2020 |
| Record Date | 01-Jun-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director for a one-year term: Dominic J. Caruso | | Management | | For | | For | |
| 1B. | | Election of Director for a one-year term: N. Anthony Coles, M.D. | | Management | | For | | For | |
| 1C. | | Election of Director for a one-year term: M. Christine Jacobs | | Management | | For | | For | |
| 1D. | | Election of Director for a one-year term: Donald R. Knauss | | Management | | For | | For | |
| 1E. | | Election of Director for a one-year term: Marie L. Knowles | | Management | | For | | For | |
| 1F. | | Election of Director for a one-year term: Bradley E. Lerman | | Management | | For | | For | |
| 1G. | | Election of Director for a one-year term: Maria Martinez | | Management | | For | | For | |
| 1H. | | Election of Director for a one-year term: Edward A. Mueller | | Management | | For | | For | |
| 1I. | | Election of Director for a one-year term: Susan R. Salka | | Management | | For | | For | |
| 1J. | | Election of Director for a one-year term: Brian S. Tyler | | Management | | For | | For | |
| 1K. | | Election of Director for a one-year term: Kenneth E. Washington, Ph.D. | | Management | | For | | For | |
| 2. | | Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2021. | | Management | | For | | For | |
| 3. | | Advisory vote on executive compensation. | | Management | | For | | For | |
| 4. | | Shareholder proposal on action by written consent of shareholders. | | Shareholder | | Against | | For | |
| 5. | | Shareholder proposal on disclosure of lobbying activities and expenditures. | | Shareholder | | Against | | For | |
| 6. | | Shareholder proposal on statement of purpose of a corporation. | | Shareholder | | Against | | For | |
MEDICAL PROPERTIES TRUST, INC.
| Security | 58463J304 | Meeting Type | Annual |
| Ticker Symbol | MPW | Meeting Date | 26-May-2021 |
| Record Date | 29-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Edward K. Aldag, Jr. | | Management | | For | | For | |
| 1B. | | Election of Director: G. Steven Dawson | | Management | | For | | For | |
| 1C. | | Election of Director: R. Steven Hamner | | Management | | For | | For | |
| 1D. | | Election of Director: Caterina A. Mozingo | | Management | | For | | For | |
| 1E. | | Election of Director: Elizabeth N. Pitman | | Management | | For | | For | |
| 1F. | | Election of Director: C. Reynolds Thompson, III | | Management | | For | | For | |
| 1G. | | Election of Director: D. Paul Sparks, Jr. | | Management | | For | | For | |
| 1H. | | Election of Director: Michael G. Stewart | | Management | | For | | For | |
| 2. | | To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | Non-binding, advisory approval of the Company's executive compensation. | | Management | | For | | For | |
MEDTRONIC PLC
| Security | G5960L103 | Meeting Type | Annual |
| Ticker Symbol | MDT | Meeting Date | 11-Dec-2020 |
| Record Date | 15-Oct-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Richard H. Anderson | | Management | | For | | For | |
| 1B. | | Election of Director: Craig Arnold | | Management | | For | | For | |
| 1C. | | Election of Director: Scott C. Donnelly | | Management | | For | | For | |
| 1D. | | Election of Director: Andrea J. Goldsmith, Ph.D. | | Management | | For | | For | |
| 1E. | | Election of Director: Randall J. Hogan, III | | Management | | For | | For | |
| 1F. | | Election of Director: Michael O. Leavitt | | Management | | For | | For | |
| 1G. | | Election of Director: James T. Lenehan | | Management | | For | | For | |
| 1H. | | Election of Director: Kevin E. Lofton | | Management | | For | | For | |
| 1I. | | Election of Director: Geoffrey S. Martha | | Management | | For | | For | |
| 1J. | | Election of Director: Elizabeth G. Nabel, M.D. | | Management | | For | | For | |
| 1K. | | Election of Director: Denise M. O'Leary | | Management | | For | | For | |
| 1L. | | Election of Director: Kendall J. Powell | | Management | | For | | For | |
| 2. | | To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2021 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration. | | Management | | For | | For | |
| 3. | | To approve, in a non-binding advisory vote, named executive officer compensation (a "Say-on-Pay" vote). | | Management | | For | | For | |
| 4. | | To renew the Board's authority to issue shares. | | Management | | For | | For | |
| 5. | | To renew the Board's authority to opt out of pre-emption rights. | | Management | | For | | For | |
| 6. | | Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. | | Management | | For | | For | |
MERCK & CO., INC.
| Security | 58933Y105 | Meeting Type | Annual |
| Ticker Symbol | MRK | Meeting Date | 25-May-2021 |
| Record Date | 26-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Leslie A. Brun | | Management | | For | | For | |
| 1B. | | Election of Director: Mary Ellen Coe | | Management | | For | | For | |
| 1C. | | Election of Director: Pamela J. Craig | | Management | | For | | For | |
| 1D. | | Election of Director: Kenneth C. Frazier | | Management | | For | | For | |
| 1E. | | Election of Director: Thomas H. Glocer | | Management | | For | | For | |
| 1F. | | Election of Director: Risa J. Lavizzo-Mourey | | Management | | For | | For | |
| 1G. | | Election of Director: Stephen L. Mayo | | Management | | For | | For | |
| 1H. | | Election of Director: Paul B. Rothman | | Management | | For | | For | |
| 1I. | | Election of Director: Patricia F. Russo | | Management | | For | | For | |
| 1J. | | Election of Director: Christine E. Seidman | | Management | | For | | For | |
| 1K. | | Election of Director: Inge G. Thulin | | Management | | For | | For | |
| 1L. | | Election of Director: Kathy J. Warden | | Management | | For | | For | |
| 1M. | | Election of Director: Peter C. Wendell | | Management | | For | | For | |
| 2. | | Non-binding advisory vote to approve the compensation of our named executive officers. | | Management | | For | | For | |
| 3. | | Ratification of the appointment of the Company's independent registered public accounting firm for 2021. | | Management | | For | | For | |
| 4. | | Shareholder proposal concerning a shareholder right to act by written consent. | | Shareholder | | Against | | For | |
| 5. | | Shareholder proposal regarding access to COVID-19 products. | | Shareholder | | Against | | For | |
METTLER-TOLEDO INTERNATIONAL INC.
| Security | 592688105 | Meeting Type | Annual |
| Ticker Symbol | MTD | Meeting Date | 06-May-2021 |
| Record Date | 08-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | ELECTION OF DIRECTORS: Robert F. Spoerry | | Management | | For | | For | |
| 1.2 | | ELECTION OF DIRECTOR: Wah-Hui Chu | | Management | | For | | For | |
| 1.3 | | ELECTION OF DIRECTOR: Domitille Doat-Le Bigot | | Management | | For | | For | |
| 1.4 | | ELECTION OF DIRECTOR: Olivier A. Filliol | | Management | | For | | For | |
| 1.5 | | ELECTION OF DIRECTOR: Elisha W. Finney | | Management | | For | | For | |
| 1.6 | | ELECTION OF DIRECTOR: Richard Francis | | Management | | For | | For | |
| 1.7 | | ELECTION OF DIRECTOR: Michael A. Kelly | | Management | | For | | For | |
| 1.8 | | ELECTION OF DIRECTOR: Thomas P. Salice | | Management | | For | | For | |
| 2. | | RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | | Management | | For | | For | |
| 3. | | ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. | | Management | | For | | For | |
| 4. | | APPROVAL OF THE METTLER-TOLEDO INTERNATIONAL INC. 2013 EQUITY INCENTIVE PLAN (AMENDED AND RESTATED EFFECTIVE AS OF MAY 6, 2021). | | Management | | For | | For | |
MOLINA HEALTHCARE, INC.
| Security | 60855R100 | Meeting Type | Annual |
| Ticker Symbol | MOH | Meeting Date | 06-May-2021 |
| Record Date | 09-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director to hold office until the 2022 Annual Meeting: Daniel Cooperman (Class I) | | Management | | For | | For | |
| 1B. | | Election of Director to hold office until the 2022 Annual Meeting: Stephen H. Lockhart (Class I) | | Management | | For | | For | |
| 1C. | | Election of Director to hold office until the 2022 Annual Meeting: Richard M. Schapiro (Class I) | | Management | | For | | For | |
| 1D. | | Election of Director to hold office until the 2022 Annual Meeting: Ronna E. Romney (Class III) | | Management | | For | | For | |
| 1E. | | Election of Director to hold office until the 2022 Annual Meeting: Dale B. Wolf (Class III) | | Management | | For | | For | |
| 1F. | | Election of Director to hold office until the 2022 Annual Meeting: Joseph M. Zubretsky (Class III) | | Management | | For | | For | |
| 2. | | To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. | | Management | | For | | For | |
| 3. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2021. | | Management | | For | | For | |
MORPHOSYS AG
| Security | 617760202 | Meeting Type | Annual |
| Ticker Symbol | MOR | Meeting Date | 19-May-2021 |
| Record Date | 09-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 2. | | Resolution on the discharge of Management Board members for the 2020 financial year. | | Management | | For | | For | |
| 3. | | Resolution on the discharge of Supervisory Board members for the 2020 financial year. | | Management | | For | | For | |
| 4. | | Resolution on the appointment of the auditor for the 2021 financial year. | | Management | | For | | For | |
| 5A. | | Election of Supervisory Board member: Dr. Marc Cluzel; (i) None; (ii) Moleac Pte. Ltd, Singapore (not listed), member of the Board of Directors; Griffon Pharmaceuticals Inc., Montreal, Canada (not listed), Member of the Board of Directors. | | Management | | For | | For | |
| 5B. | | Election of Supervisory Board member: Ms. Krisja Vermeylen; (i) None; (ii) Diaverum AB, Lund, Sweden (not listed), Member of the Board of Directors. | | Management | | For | | For | |
| 5C. | | Election of Supervisory Board member: Ms. Sharon Curran; (i) None; (ii) Circassia Pharmaceuticals plc, Oxford, United Kingdom (listed), member of the Board of Directors. | | Management | | For | | For | |
| 6. | | Resolution on the cancellation of Authorized Capital 2018-I and the creation of a new Authorized Capital 2021-I with the option to exclude statutory subscription rights; amendment to the Articles of Association. | | Management | | For | | For | |
| 7. | | Resolution on the cancellation of Authorized Capital 2020-I and the creation of a new Authorized Capital 2021-II with the option to exclude statutory subscription rights; amendment to the Articles of Association. | | Management | | For | | For | |
| 8. | | Resolution on the creation of an Authorized Capital 2021- III under exclusion of subscription rights for the purpose of serving "Restricted Stock Units" to be issued to senior managers and employees of MorphoSys US Inc. under the "Restricted Stock Unit Program 2021" of the Company; amendment to the Articles of Association. | | Management | | For | | For | |
| 9. | | Resolution on the cancellation of Conditional Capital 2008-III, the reduction of Conditional Capital 2016-I and the reduction of Conditional Capital 2016-III; amendments to the Articles of Association. | | Management | | For | | For | |
| 10. | | Resolution on the creation of a new Conditional Capital 2021-I and the authorization of the Management Board to issue convertible bonds/bonds with warrants with the option to exclude subscription rights; amendment to the Articles of Association. | | Management | | For | | For | |
| 11. | | Resolution on the approval of the remuneration system for members of the Management Board. | | Management | | For | | For | |
| 12. | | Resolution on the remuneration of the members of the Supervisory Board. | | Management | | For | | For | |
| 13. | | Resolution on further amendments to the Articles of Association. | | Management | | For | | For | |
NATIONAL HEALTH INVESTORS, INC.
| Security | 63633D104 | Meeting Type | Annual |
| Ticker Symbol | NHI | Meeting Date | 04-May-2021 |
| Record Date | 12-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Robert T. Webb | | Management | | For | | For | |
| 1B. | | Election of Director: Charlotte A. Swafford | | Management | | For | | For | |
| 1C. | | Election of Director: D. Eric Mendelsohn | | Management | | For | | For | |
| 2. | | Approve the advisory resolution approving the compensation of the named executive officers as disclosed in the accompanying Proxy Statement. | | Management | | For | | For | |
| 3. | | Ratify the audit committee's selection of BDO USA, LLP as independent registered public accounting firm for the year ending December 31, 2021. | | Management | | For | | For | |
NEKTAR THERAPEUTICS
| Security | 640268108 | Meeting Type | Annual |
| Ticker Symbol | NKTR | Meeting Date | 10-Jun-2021 |
| Record Date | 12-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Jeff Ajer | | Management | | For | | For | |
| 1B. | | Election of Director: Robert B. Chess | | Management | | For | | For | |
| 1C. | | Election of Director: Roy A. Whitfield | | Management | | For | | For | |
| 2. | | To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,000,000 shares. | | Management | | For | | For | |
| 3. | | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 4. | | To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). | | Management | | For | | For | |
NEW SENIOR INVESTMENT GROUP INC.
| Security | 648691103 | Meeting Type | Annual |
| Ticker Symbol | SNR | Meeting Date | 27-May-2021 |
| Record Date | 01-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Norman K. Jenkins | | Management | | For | | For | |
| 1B. | | Election of Director: Cassia van der Hoof Holstein | | Management | | For | | For | |
| 2. | | Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for fiscal year 2021. | | Management | | For | | For | |
| 3. | | Approval of an advisory vote on the compensation of the company's named executive officers. | | Management | | For | | For | |
NOVARTIS AG
| Security | 66987V109 | Meeting Type | Annual |
| Ticker Symbol | NVS | Meeting Date | 02-Mar-2021 |
| Record Date | 22-Jan-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | Approval of the Operating and Financial Review of Novartis AG, the Financial Statements of Novartis AG and the Group Consolidated Financial Statements for the 2020 Financial Year. | | Management | | For | | For | |
| 2. | | Discharge from Liability of the Members of the Board of Directors and the Executive Committee. | | Management | | For | | For | |
| 3. | | Appropriation of Available Earnings of Novartis AG as per Balance Sheet and Declaration of Dividend for 2020. | | Management | | For | | For | |
| 4. | | Reduction of Share Capital. | | Management | | For | | For | |
| 5. | | Further Share Repurchases. | | Management | | For | | For | |
| 6A. | | Binding Vote on the Maximum Aggregate Amount of Compensation for the Board of Directors from the 2021 Annual General Meeting to the 2022 Annual General Meeting. | | Management | | For | | For | |
| 6B. | | Binding Vote on the Maximum Aggregate Amount of Compensation for the Executive Committee for the Financial Year 2022. | | Management | | For | | For | |
| 6C. | | Advisory Vote on the 2020 Compensation Report. | | Management | | For | | For | |
| 7A. | | Re-election of Joerg Reinhardt as Member and Chairman. | | Management | | For | | For | |
| 7B. | | Re-election of Nancy C. Andrews | | Management | | For | | For | |
| 7C. | | Re-election of Ton Buechner | | Management | | For | | For | |
| 7D. | | Re-election of Patrice Bula | | Management | | For | | For | |
| 7E. | | Re-election of Elizabeth Doherty | | Management | | For | | For | |
| 7F. | | Re-election of Ann Fudge | | Management | | For | | For | |
| 7G. | | Re-election of Bridgette Heller | | Management | | For | | For | |
| 7H. | | Re-election of Frans van Houten | | Management | | For | | For | |
| 7I. | | Re-election of Simon Moroney | | Management | | For | | For | |
| 7J. | | Re-election of Andreas von Planta | | Management | | For | | For | |
| 7K. | | Re-election of Charles L. Sawyers | | Management | | For | | For | |
| 7L. | | Re-election of Enrico Vanni | | Management | | For | | For | |
| 7M. | | Re-election of William T. Winters | | Management | | For | | For | |
| 8A. | | Re-election of Patrice Bula to the Compensation Committee. | | Management | | For | | For | |
| 8B. | | Re-election of Bridgette Heller to the Compensation Committee. | | Management | | For | | For | |
| 8C. | | Re-election of Enrico Vanni to the Compensation Committee. | | Management | | For | | For | |
| 8D. | | Re-Election of William T. Winters to the Compensation Committee. | | Management | | For | | For | |
| 8E. | | Election of Simon Moroney to the Compensation Committee. | | Management | | For | | For | |
| 9. | | Re-election of the Statutory Auditor. | | Management | | For | | For | |
| 10. | | Re-election of the Independent Proxy. | | Management | | For | | For | |
| 11. | | Amendment to Article 20 Paragraph 3 of the Articles of Incorporation. | | Management | | For | | For | |
| 12. | | General instructions in case of alternative motions under the agenda items published in the Notice of Annual General Meeting, and/or of motions relating to additional agenda items according to Article 700 paragraph 3 of the Swiss Code of Obligations. | | Management | | For | | For | |
OCULIS SA
| Security | N/A | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 24-Jun-2021 |
| Record Date | N/A | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | Approval of the Annual Report including Financial Statements 2020 | | Management | | For | | For | |
| 2 | | Allocation of Balance Sheet Results 2020 | | Management | | For | | For | |
| 3 | | Discharge to Members of the Board of Directors and the Management | | Management | | For | | For | |
| 4 | | Re-Election of the Members of the Board of Directors | | Management | | For | | For | |
| 5 | | Re-Election of the Auditors PricewaterhouseCoopers SA | | Management | | For | | For | |
OLYMPUS CORPORATION
| Security | J61240107 | Meeting Type | ExtraOrdinary General Meeting |
| Ticker Symbol | N/A | Meeting Date | 30-Jul-2020 |
| Record Date | 31-May-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | The Transfer Agent in Japan for this event requires it be registered as an-"EGM" though the event will be conducted as an "AGM" | | Non-Voting | | | | | |
| 1 | | Approve Appropriation of Surplus | | Management | | For | | For | |
| 2 | | Amend Articles to: Allow the Board of Directors to Authorize Appropriation of Surplus and Purchase Own Shares | | Management | | For | | For | |
| 3.1 | | Appoint a Director Takeuchi, Yasuo | | Management | | For | | For | |
| 3.2 | | Appoint a Director Fujita, Sumitaka | | Management | | For | | For | |
| 3.3 | | Appoint a Director Kaminaga, Susumu | | Management | | For | | For | |
| 3.4 | | Appoint a Director Kikawa, Michijiro | | Management | | For | | For | |
| 3.5 | | Appoint a Director Iwamura, Tetsuo | | Management | | For | | For | |
| 3.6 | | Appoint a Director Masuda, Yasumasa | | Management | | For | | For | |
| 3.7 | | Appoint a Director Natori, Katsuya | | Management | | For | | For | |
| 3.8 | | Appoint a Director Iwasaki, Atsushi | | Management | | For | | For | |
| 3.9 | | Appoint a Director David Robert Hale | | Management | | For | | For | |
| 3.10 | | Appoint a Director Jimmy C. Beasley | | Management | | For | | For | |
| 3.11 | | Appoint a Director Stefan Kaufmann | | Management | | For | | For | |
| 3.12 | | Appoint a Director Koga, Nobuyuki | | Management | | For | | For | |
OLYMPUS CORPORATION
| Security | J61240107 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 24-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1.1 | | Appoint a Director Takeuchi, Yasuo | | Management | | For | | For | |
| 1.2 | | Appoint a Director Fujita, Sumitaka | | Management | | For | | For | |
| 1.3 | | Appoint a Director Kaminaga, Susumu | | Management | | For | | For | |
| 1.4 | | Appoint a Director Iwamura, Tetsuo | | Management | | For | | For | |
| 1.5 | | Appoint a Director Masuda, Yasumasa | | Management | | For | | For | |
| 1.6 | | Appoint a Director Iwasaki, Atsushi | | Management | | For | | For | |
| 1.7 | | Appoint a Director David Robert Hale | | Management | | For | | For | |
| 1.8 | | Appoint a Director Jimmy C. Beasley | | Management | | For | | For | |
| 1.9 | | Appoint a Director Ichikawa, Sachiko | | Management | | For | | For | |
| 1.10 | | Appoint a Director Stefan Kaufmann | | Management | | For | | For | |
| 1.11 | | Appoint a Director Koga, Nobuyuki | | Management | | For | | For | |
OMEGA HEALTHCARE INVESTORS, INC.
| Security | 681936100 | Meeting Type | Annual |
| Ticker Symbol | OHI | Meeting Date | 03-Jun-2021 |
| Record Date | 06-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Kapila K. Anand | | | | For | | For | |
| | | 2 | Craig R. Callen | | | | For | | For | |
| | | 3 | Barbara B. Hill | | | | For | | For | |
| | | 4 | Kevin J. Jacobs | | | | For | | For | |
| | | 5 | Edward Lowenthal | | | | For | | For | |
| | | 6 | C. Taylor Pickett | | | | For | | For | |
| | | 7 | Stephen D. Plavin | | | | For | | For | |
| | | 8 | Burke W. Whitman | | | | For | | For | |
| 2. | | Ratification of Independent Auditors Ernst & Young LLP for fiscal year 2021. | | Management | | For | | For | |
| 3. | | Approval, on an Advisory Basis, of Executive Compensation. | | Management | | For | | For | |
ONO PHARMACEUTICAL CO.,LTD.
| Security | J61546115 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 17-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1 | | Approve Appropriation of Surplus | | Management | | For | | For | |
| 2.1 | | Appoint a Director Sagara, Gyo | | Management | | For | | For | |
| 2.2 | | Appoint a Director Tsujinaka, Toshihiro | | Management | | For | | For | |
| 2.3 | | Appoint a Director Takino, Toichi | | Management | | For | | For | |
| 2.4 | | Appoint a Director Ono, Isao | | Management | | For | | For | |
| 2.5 | | Appoint a Director Idemitsu, Kiyoaki | | Management | | For | | For | |
| 2.6 | | Appoint a Director Nomura, Masao | | Management | | For | | For | |
| 2.7 | | Appoint a Director Okuno, Akiko | | Management | | For | | For | |
| 2.8 | | Appoint a Director Nagae, Shusaku | | Management | | For | | For | |
| 3 | | Appoint a Corporate Auditor Tanisaka, Hironobu | | Management | | For | | For | |
| 4 | | Approve Details of Compensation as Stock-Linked Compensation Type Stock Options for Directors | | Management | | For | | For | |
OTSUKA HOLDINGS CO.,LTD.
| Security | J63117105 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 30-Mar-2021 |
| Record Date | 31-Dec-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1.1 | | Appoint a Director Otsuka, Ichiro | | Management | | For | | For | |
| 1.2 | | Appoint a Director Higuchi, Tatsuo | | Management | | For | | For | |
| 1.3 | | Appoint a Director Matsuo, Yoshiro | | Management | | For | | For | |
| 1.4 | | Appoint a Director Makino, Yuko | | Management | | For | | For | |
| 1.5 | | Appoint a Director Takagi, Shuichi | | Management | | For | | For | |
| 1.6 | | Appoint a Director Tobe, Sadanobu | | Management | | For | | For | |
| 1.7 | | Appoint a Director Kobayashi, Masayuki | | Management | | For | | For | |
| 1.8 | | Appoint a Director Tojo, Noriko | | Management | | For | | For | |
| 1.9 | | Appoint a Director Inoue, Makoto | | Management | | For | | For | |
| 1.10 | | Appoint a Director Matsutani, Yukio | | Management | | For | | For | |
| 1.11 | | Appoint a Director Sekiguchi, Ko | | Management | | For | | For | |
| 1.12 | | Appoint a Director Aoki, Yoshihisa | | Management | | For | | For | |
| 1.13 | | Appoint a Director Mita, Mayo | | Management | | For | | For | |
| 2 | | Appoint Accounting Auditors | | Management | | For | | For | |
OWENS & MINOR, INC.
| Security | 690732102 | Meeting Type | Annual |
| Ticker Symbol | OMI | Meeting Date | 29-Apr-2021 |
| Record Date | 05-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Election of Director for the term of one-year: Aster Angagaw | | Management | | For | | For | |
| 1.2 | | Election of Director for the term of one-year: Mark A. Beck | | Management | | For | | For | |
| 1.3 | | Election of Director for the term of one-year: Gwendolyn M. Bingham | | Management | | For | | For | |
| 1.4 | | Election of Director for the term of one-year: Robert J. Henkel | | Management | | For | | For | |
| 1.5 | | Election of Director for the term of one-year: Stephen W. Klemash | | Management | | For | | For | |
| 1.6 | | Election of Director for the term of one-year: Mark F. McGettrick | | Management | | For | | For | |
| 1.7 | | Election of Director for the term of one-year: Edward A. Pesicka | | Management | | For | | For | |
| 1.8 | | Election of Director for the term of one-year: Michael C. Riordan | | Management | | For | | For | |
| 2. | | Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | Advisory vote to approve the compensation of the Company's named executive officers. | | Management | | For | | For | |
PERKINELMER, INC.
| Security | 714046109 | Meeting Type | Annual |
| Ticker Symbol | PKI | Meeting Date | 27-Apr-2021 |
| Record Date | 01-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director for one year term: Peter Barrett, PhD | | Management | | For | | For | |
| 1B. | | Election of Director for one year term: Samuel R. Chapin | | Management | | For | | For | |
| 1C. | | Election of Director for one year term: Sylvie Grégoire, PharmD | | Management | | For | | For | |
| 1D. | | Election of Director for one year term: Alexis P. Michas | | Management | | For | | For | |
| 1E. | | Election of Director for one year term: Prahlad R. Singh, PhD | | Management | | For | | For | |
| 1F. | | Election of Director for one year term: Michel Vounatsos | | Management | | For | | For | |
| 1G. | | Election of Director for one year term: Frank Witney, PhD | | Management | | For | | For | |
| 1H. | | Election of Director for one year term: Pascale Witz | | Management | | For | | For | |
| 2. | | To ratify the selection of Deloitte & Touche LLP as PerkinElmer's independent registered public accounting firm for the current fiscal year. | | Management | | For | | For | |
| 3. | | To approve, by non-binding advisory vote, our executive compensation. | | Management | | For | | For | |
PERRIGO COMPANY PLC
| Security | G97822103 | Meeting Type | Annual |
| Ticker Symbol | PRGO | Meeting Date | 12-May-2021 |
| Record Date | 15-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Bradley A. Alford | | Management | | For | | For | |
| 1B. | | Election of Director: Orlando D. Ashford | | Management | | For | | For | |
| 1C. | | Election of Director: Rolf A. Classon | | Management | | For | | For | |
| 1D. | | Election of Director: Katherine C. Doyle | | Management | | For | | For | |
| 1E. | | Election of Director: Adriana Karaboutis | | Management | | For | | For | |
| 1F. | | Election of Director: Murray S. Kessler | | Management | | For | | For | |
| 1G. | | Election of Director: Jeffrey B. Kindler | | Management | | For | | For | |
| 1H. | | Election of Director: Erica L. Mann | | Management | | For | | For | |
| 1I. | | Election of Director: Donal O'Connor | | Management | | For | | For | |
| 1J. | | Election of Director: Geoffrey M. Parker | | Management | | For | | For | |
| 1K. | | Election of Director: Theodore R. Samuels | | Management | | For | | For | |
| 2. | | Ratify the appointment of Ernst & Young LLP as our independent auditor for the period ending December 31, 2021 and authorize the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor. | | Management | | For | | For | |
| 3. | | Advisory vote on the Company's executive compensation. | | Management | | For | | For | |
| 4. | | Renew the Board's authority to issue shares under Irish law. | | Management | | For | | For | |
| 5. | | Renew the Board's authority to opt-out of statutory pre- emption rights under Irish law. | | Management | | For | | For | |
PFIZER INC.
| Security | 717081103 | Meeting Type | Annual |
| Ticker Symbol | PFE | Meeting Date | 22-Apr-2021 |
| Record Date | 24-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Ronald E. Blaylock | | Management | | For | | For | |
| 1B. | | Election of Director: Albert Bourla | | Management | | For | | For | |
| 1C. | | Election of Director: Susan Desmond-Hellmann | | Management | | For | | For | |
| 1D. | | Election of Director: Joseph J. Echevarria | | Management | | For | | For | |
| 1E. | | Election of Director: Scott Gottlieb | | Management | | For | | For | |
| 1F. | | Election of Director: Helen H. Hobbs | | Management | | For | | For | |
| 1G. | | Election of Director: Susan Hockfield | | Management | | For | | For | |
| 1H. | | Election of Director: Dan R. Littman | | Management | | For | | For | |
| 1I. | | Election of Director: Shantanu Narayen | | Management | | For | | For | |
| 1J. | | Election of Director: Suzanne Nora Johnson | | Management | | For | | For | |
| 1K. | | Election of Director: James Quincey | | Management | | For | | For | |
| 1L. | | Election of Director: James C. Smith | | Management | | For | | For | |
| 2. | | Ratify the selection of KPMG LLP as independent registered public accounting firm for 2021. | | Management | | For | | For | |
| 3. | | 2021 advisory approval of executive compensation. | | Management | | For | | For | |
| 4. | | Shareholder proposal regarding independent chair policy. | | Shareholder | | For | | Against | |
| 5. | | Shareholder proposal regarding political spending report. | | Shareholder | | Against | | For | |
| 6. | | Shareholder proposal regarding access to COVID-19 products. | | Shareholder | | Against | | For | |
PHYSICIANS REALTY TRUST
| Security | 71943U104 | Meeting Type | Annual |
| Ticker Symbol | DOC | Meeting Date | 05-May-2021 |
| Record Date | 25-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | John T. Thomas | | | | For | | For | |
| | | 2 | Tommy G. Thompson | | | | For | | For | |
| | | 3 | Stanton D. Anderson | | | | For | | For | |
| | | 4 | Mark A. Baumgartner | | | | For | | For | |
| | | 5 | Albert C. Black, Jr. | | | | For | | For | |
| | | 6 | William A. Ebinger, M.D | | | | For | | For | |
| | | 7 | Pamela J. Kessler | | | | For | | For | |
| | | 8 | Richard A. Weiss | | | | For | | For | |
| 2. | | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. | | Management | | For | | For | |
R1 RCM INC.
| Security | 749397105 | Meeting Type | Annual |
| Ticker Symbol | RCM | Meeting Date | 20-May-2021 |
| Record Date | 23-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Michael C. Feiner | | | | For | | For | |
| | | 2 | Joseph Flanagan | | | | For | | For | |
| | | 3 | John B. Henneman, III | | | | For | | For | |
| | | 4 | Alex J. Mandl | | | | For | | For | |
| | | 5 | Neal Moszkowski | | | | For | | For | |
| | | 6 | Ian Sacks | | | | For | | For | |
| | | 7 | Jill Smith | | | | For | | For | |
| | | 8 | Anthony J. Speranzo | | | | For | | For | |
| | | 9 | Anthony R. Tersigni | | | | For | | For | |
| | | 10 | Albert R. Zimmerli | | | | For | | For | |
| 2. | | To approve our Third Amended and Restated 2010 Stock Incentive Plan. | | Management | | For | | For | |
| 3. | | To approve, on an advisory basis, the compensation of our named executive officers. | | Management | | For | | For | |
| 4. | | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 5A. | | Election of Additional Director: David M. Dill | | Management | | For | | For | |
REGENERON PHARMACEUTICALS, INC.
| Security | 75886F107 | Meeting Type | Annual |
| Ticker Symbol | REGN | Meeting Date | 11-Jun-2021 |
| Record Date | 13-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: N. Anthony Coles, M.D. | | Management | | For | | For | |
| 1B. | | Election of Director: Arthur F. Ryan | | Management | | For | | For | |
| 1C. | | Election of Director: George L. Sing | | Management | | For | | For | |
| 1D. | | Election of Director: Marc Tessier-Lavigne, Ph.D. | | Management | | For | | For | |
| 2. | | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
SABRA HEALTH CARE REIT, INC.
| Security | 78573L106 | Meeting Type | Annual |
| Ticker Symbol | SBRA | Meeting Date | 16-Jun-2021 |
| Record Date | 19-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Craig A. Barbarosh | | Management | | For | | For | |
| 1B. | | Election of Director: Katie Cusack | | Management | | For | | For | |
| 1C. | | Election of Director: Michael J. Foster | | Management | | For | | For | |
| 1D. | | Election of Director: Ronald G. Geary | | Management | | For | | For | |
| 1E. | | Election of Director: Lynne S. Katzmann | | Management | | For | | For | |
| 1F. | | Election of Director: Ann Kono | | Management | | For | | For | |
| 1G. | | Election of Director: Raymond J. Lewis | | Management | | For | | For | |
| 1H. | | Election of Director: Jeffrey A. Malehorn | | Management | | For | | For | |
| 1I. | | Election of Director: Richard K. Matros | | Management | | For | | For | |
| 1J. | | Election of Director: Clifton J. Porter II | | Management | | For | | For | |
| 1K. | | Election of Director: Milton J. Walters | | Management | | For | | For | |
| 2. | | Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | Approval, on an advisory basis, of the compensation of Sabra's named executive officers. | | Management | | For | | For | |
SANOFI
| Security | 80105N105 | Meeting Type | Annual |
| Ticker Symbol | SNY | Meeting Date | 30-Apr-2021 |
| Record Date | 29-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | Approval of the individual company financial statements for the year ended December 31, 2020. | | Management | | For | | For | |
| 2. | | Approval of the consolidated financial statements for the year ended December 31, 2020. | | Management | | For | | For | |
| 3. | | Appropriation of results for the year ended December 31, 2020 and declaration of dividend. | | Management | | For | | For | |
| 4. | | Ratification of the co-opting of Gilles Schnepp as a director. | | Management | | For | | For | |
| 5. | | Reappointment of Fabienne Lecorvaisier as a Director. | | Management | | For | | For | |
| 6. | | Reappointment of Melanie Lee as a director. | | Management | | For | | For | |
| 7. | | Appointment of Barbara Lavernos as a director. | | Management | | For | | For | |
| 8. | | Approval of the report on the compensation of corporate officers issued in accordance with Article L. 22-10-9 of the French Commercial Code. | | Management | | For | | For | |
| 9. | | Approval of the components of the compensation paid or awarded in respect of the year ended December 31, 2020 to Serge Weinberg, Chairman of the Board. | | Management | | For | | For | |
| 10. | | Approval of the components of the compensation paid or awarded in respect of the year ended December 31, 2020 to Paul Hudson, Chief Executive Officer. | | Management | | For | | For | |
| 11. | | Approval of the compensation policy for directors. | | Management | | For | | For | |
| 12. | | Approval of the compensation policy for the Chairman of the Board of Directors. | | Management | | For | | For | |
| 13. | | Approval of the compensation policy for the Chief Executive Officer. | | Management | | For | | For | |
| 14. | | Authorization to the Board of Directors to carry out transactions in the Company's shares (usable outside the period of a public tender offer). | | Management | | For | | For | |
| 15. | | Authorization to the Board of Directors to reduce the share capital by cancellation of treasury shares. | | Management | | For | | For | |
| 16. | | Delegation to the Board of Directors of competence to decide to ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | For | |
| 17. | | Delegation to the Board of Directors of competence to decide to ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | For | |
| 18. | | Delegation to the Board of Directors of competence to decide to ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | For | |
| 19. | | Delegation to the Board of Directors of competence to decide to ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | For | |
| 20. | | Delegation to the Board of Directors of competence to increase ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | For | |
| 21. | | Delegation to the Board of Directors of competence with a view ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | For | |
| 22. | | Delegation to the Board of Directors of competence to decide to ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | For | |
| 23. | | Delegation to the Board of Directors of competence to decide on ...(due to space limits, see proxy statement for full proposal). | | Management | | For | | For | |
| 24. | | Authorization to the Board of Directors to carry out consideration-free allotments of existing or new shares to some or all of the salaried employees and corporate officers of the Group. | | Management | | For | | For | |
| 25. | | Amendment to Article 13 of the Articles of Association to allow the Board of Directors to take decisions by written consultation. | | Management | | For | | For | |
| 26. | | Amendment to Articles 14 and 17 of the Articles of Association to align their content with the PACTE law. | | Management | | For | | For | |
| 27. | | Powers for formalities. | | Management | | For | | For | |
SHIONOGI & CO.,LTD.
| Security | J74229105 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 22-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1 | | Approve Appropriation of Surplus | | Management | | For | | For | |
| 2.1 | | Appoint a Director Teshirogi, Isao | | Management | | For | | For | |
| 2.2 | | Appoint a Director Sawada, Takuko | | Management | | For | | For | |
| 2.3 | | Appoint a Director Ando, Keiichi | | Management | | For | | For | |
| 2.4 | | Appoint a Director Ozaki, Hiroshi | | Management | | For | | For | |
| 2.5 | | Appoint a Director Takatsuki, Fumi | | Management | | For | | For | |
| 3 | | Appoint a Corporate Auditor Fujiwara, Takaoki | | Management | | For | | For | |
SMITH & NEPHEW PLC
| Security | 83175M205 | Meeting Type | Annual |
| Ticker Symbol | SNN | Meeting Date | 14-Apr-2021 |
| Record Date | 22-Feb-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | To receive the audited accounts. | | Management | | For | | For | |
| 2. | | To approve the Directors' Remuneration Report (excluding policy). | | Management | | For | | For | |
| 3. | | To declare a final dividend. | | Management | | For | | For | |
| 4. | | ELECTION/RE-ELECTION OF DIRECTOR: Roland Diggelmann | | Management | | For | | For | |
| 5. | | ELECTION/RE-ELECTION OF DIRECTOR: Erik Engstrom | | Management | | For | | For | |
| 6. | | ELECTION/RE-ELECTION OF DIRECTOR: Robin Freestone | | Management | | For | | For | |
| 7. | | ELECTION/RE-ELECTION OF DIRECTOR: John Ma | | Management | | For | | For | |
| 8. | | ELECTION/RE-ELECTION OF DIRECTOR: Katarzyna Mazur-Hofsaess | | Management | | For | | For | |
| 9. | | ELECTION/RE-ELECTION OF DIRECTOR: Rick Medlock | | Management | | For | | For | |
| 10. | | ELECTION/RE-ELECTION OF DIRECTOR: Anne- Françoise Nesmes | | Management | | For | | For | |
| 11. | | ELECTION/RE-ELECTION OF DIRECTOR: Marc Owen | | Management | | For | | For | |
| 12. | | ELECTION/RE-ELECTION OF DIRECTOR: Roberto Quarta | | Management | | For | | For | |
| 13. | | ELECTION/RE-ELECTION OF DIRECTOR: Angie Risley | | Management | | For | | For | |
| 14. | | ELECTION/RE-ELECTION OF DIRECTOR: Bob White | | Management | | For | | For | |
| 15. | | To re-appoint the Auditor. | | Management | | For | | For | |
| 16. | | To authorise Directors' to determine the remuneration of the Auditor. | | Management | | For | | For | |
| 17. | | To renew the Directors' authority to allot shares. | | Management | | For | | For | |
| 18. | | To renew the Directors' authority for the disapplication of the pre-emption rights. | | Management | | For | | For | |
| 19. | | To authorise the Directors to disapply pre-emption rights for the purposes of acquisitions or other capital investments. | | Management | | For | | For | |
| 20. | | To renew the Directors' limited authority to make market purchases of the Company's own shares. | | Management | | For | | For | |
| 21. | | To authorise general meetings to be held on 14 clear days' notice. | | Management | | For | | For | |
| 22. | | To approve the new Articles of Association. | | Management | | For | | For | |
SOSEI GROUP CORPORATION
| Security | J7637L109 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 24-Mar-2021 |
| Record Date | 31-Dec-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1.1 | | Appoint a Director Tamura, Shinichi | | Management | | For | | For | |
| 1.2 | | Appoint a Director Toyama, Tomohiro | | Management | | For | | For | |
| 1.3 | | Appoint a Director Kaga, Kuniaki | | Management | | For | | For | |
| 1.4 | | Appoint a Director David Roblin | | Management | | For | | For | |
| 1.5 | | Appoint a Director Nagai, Noriaki | | Management | | For | | For | |
| 1.6 | | Appoint a Director Rolf Soderstrom | | Management | | For | | For | |
STRYKER CORPORATION
| Security | 863667101 | Meeting Type | Annual |
| Ticker Symbol | SYK | Meeting Date | 05-May-2021 |
| Record Date | 08-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A) | | Election of Director: Mary K. Brainerd | | Management | | For | | For | |
| 1B) | | Election of Director: Giovanni Caforio, M.D. | | Management | | For | | For | |
| 1C) | | Election of Director: Srikant M. Datar, Ph.D. | | Management | | For | | For | |
| 1D) | | Election of Director: Allan C. Golston (Lead Independent Director) | | Management | | For | | For | |
| 1E) | | Election of Director: Kevin A. Lobo (Chair of the Board and Chief Executive Officer) | | Management | | For | | For | |
| 1F) | | Election of Director: Sherilyn S. McCoy | | Management | | For | | For | |
| 1G) | | Election of Director: Andrew K. Silvernail | | Management | | For | | For | |
| 1H) | | Election of Director: Lisa M. Skeete Tatum | | Management | | For | | For | |
| 1I) | | Election of Director: Ronda E. Stryker | | Management | | For | | For | |
| 1J) | | Election of Director: Rajeev Suri | | Management | | For | | For | |
| 2. | | Ratification of Appointment of our Independent Registered Public Accounting Firm. | | Management | | For | | For | |
| 3. | | Advisory Vote to Approve Named Executive Officer Compensation. | | Management | | For | | For | |
| 4. | | Shareholder Proposal Regarding Workforce Involvement in Corporate Governance. | | Shareholder | | Against | | For | |
| 5. | | Shareholder Proposal Regarding Right to Call Special Meetings | | Shareholder | | Against | | For | |
SYSMEX CORPORATION
| Security | J7864H102 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 25-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1 | | Approve Appropriation of Surplus | | Management | | For | | For | |
| 2.1 | | Appoint a Director who is not Audit and Supervisory Committee Member Ietsugu, Hisashi | | Management | | For | | For | |
| 2.2 | | Appoint a Director who is not Audit and Supervisory Committee Member Asano, Kaoru | | Management | | For | | For | |
| 2.3 | | Appoint a Director who is not Audit and Supervisory Committee Member Tachibana, Kenji | | Management | | For | | For | |
| 2.4 | | Appoint a Director who is not Audit and Supervisory Committee Member Matsui, Iwane | | Management | | For | | For | |
| 2.5 | | Appoint a Director who is not Audit and Supervisory Committee Member Kanda, Hiroshi | | Management | | For | | For | |
| 2.6 | | Appoint a Director who is not Audit and Supervisory Committee Member Yoshida, Tomokazu | | Management | | For | | For | |
| 2.7 | | Appoint a Director who is not Audit and Supervisory Committee Member Takahashi, Masayo | | Management | | For | | For | |
| 2.8 | | Appoint a Director who is not Audit and Supervisory Committee Member Ota, Kazuo | | Management | | For | | For | |
| 2.9 | | Appoint a Director who is not Audit and Supervisory Committee Member Fukumoto, Hidekazu | | Management | | For | | For | |
| 3 | | Appoint a Substitute Director who is Audit and Supervisory Committee Member Onishi, Koichi | | Management | | For | | For | |
TAKEDA PHARMACEUTICAL CO LTD
| Security | 874060205 | Meeting Type | Annual |
| Ticker Symbol | TAK | Meeting Date | 29-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1 | | Appropriation of Surplus | | Management | | For | | | |
| 2 | | Partial Amendment to the Articles of Incorporation | | Management | | For | | | |
| 3A | | Election of Director who is not Audit and Supervisory Committee Member: Christophe Weber | | Management | | For | | | |
| 3B | | Election of Director who is not Audit and Supervisory Committee Member: Masato Iwasaki | | Management | | For | | | |
| 3C | | Election of Director who is not Audit and Supervisory Committee Member: Andrew Plump | | Management | | For | | | |
| 3D | | Election of Director who is not Audit and Supervisory Committee Member: Costa Saroukos | | Management | | For | | | |
| 3E | | Election of Director who is not Audit and Supervisory Committee Member: Masahiro Sakane | | Management | | For | | | |
| 3F | | Election of Director who is not Audit and Supervisory Committee Member: Oliver Bohuon | | Management | | For | | | |
| 3G | | Election of Director who is not Audit and Supervisory Committee Member: Jean-Luc Butel | | Management | | For | | | |
| 3H | | Election of Director who is not Audit and Supervisory Committee Member: Ian Clark | | Management | | For | | | |
| 3I | | Election of Director who is not Audit and Supervisory Committee Member: Yoshiaki Fujimori | | Management | | For | | | |
| 3J | | Election of Director who is not Audit and Supervisory Committee Member: Steven Gillis | | Management | | For | | | |
| 3K | | Election of Director who is not Audit and Supervisory Committee Member: Shiro Kuniya | | Management | | For | | | |
| 3L | | Election of Director who is not Audit and Supervisory Committee Member: Toshiyuki Shiga | | Management | | For | | | |
| 4.1 | | Election of Director who is an Audit and Supervisory Committee Member: Masami Iijima | | Management | | For | | | |
| 5 | | Payment of Bonuses to Directors who are not Audit and Supervisory Committee Members | | Management | | For | | | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED
| Security | J8129E108 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 29-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1 | | Approve Appropriation of Surplus | | Management | | For | | For | |
| 2 | | Amend Articles to: Establish the Articles Related to Shareholders Meeting held without specifying a venue | | Management | | For | | For | |
| 3.1 | | Appoint a Director who is not Audit and Supervisory Committee Member Christophe Weber | | Management | | For | | For | |
| 3.2 | | Appoint a Director who is not Audit and Supervisory Committee Member Iwasaki, Masato | | Management | | For | | For | |
| 3.3 | | Appoint a Director who is not Audit and Supervisory Committee Member Andrew Plump | | Management | | For | | For | |
| 3.4 | | Appoint a Director who is not Audit and Supervisory Committee Member Constantine Saroukos | | Management | | For | | For | |
| 3.5 | | Appoint a Director who is not Audit and Supervisory Committee Member Sakane, Masahiro | | Management | | For | | For | |
| 3.6 | | Appoint a Director who is not Audit and Supervisory Committee Member Olivier Bohuon | | Management | | For | | For | |
| 3.7 | | Appoint a Director who is not Audit and Supervisory Committee Member Jean-Luc Butel | | Management | | For | | For | |
| 3.8 | | Appoint a Director who is not Audit and Supervisory Committee Member Ian Clark | | Management | | For | | For | |
| 3.9 | | Appoint a Director who is not Audit and Supervisory Committee Member Fujimori, Yoshiaki | | Management | | For | | For | |
| 3.10 | | Appoint a Director who is not Audit and Supervisory Committee Member Steven Gillis | | Management | | For | | For | |
| 3.11 | | Appoint a Director who is not Audit and Supervisory Committee Member Kuniya, Shiro | | Management | | For | | For | |
| 3.12 | | Appoint a Director who is not Audit and Supervisory Committee Member Shiga, Toshiyuki | | Management | | For | | For | |
| 4 | | Appoint a Director who is Audit and Supervisory Committee Member Iijima, Masami | | Management | | For | | For | |
| 5 | | Approve Payment of Bonuses to Directors (Excluding Directors who are Audit and Supervisory Committee Members) | | Management | | For | | For | |
TELADOC HEALTH, INC.
| Security | 87918A105 | Meeting Type | Annual |
| Ticker Symbol | TDOC | Meeting Date | 17-May-2021 |
| Record Date | 23-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director for a term of one year: Christopher Bischoff | | Management | | For | | For | |
| 1B. | | Election of Director for a term of one year: Karen L. Daniel | | Management | | For | | For | |
| 1C. | | Election of Director for a term of one year: Sandra L. Fenwick | | Management | | For | | For | |
| 1D. | | Election of Director for a term of one year: William H. Frist, MD | | Management | | For | | For | |
| 1E. | | Election of Director for a term of one year: Jason Gorevic | | Management | | For | | For | |
| 1F. | | Election of Director for a term of one year: Catherine A. Jacobson | | Management | | For | | For | |
| 1G. | | Election of Director for a term of one year: Thomas G. McKinley | | Management | | For | | For | |
| 1H. | | Election of Director for a term of one year: Kenneth H. Paulus | | Management | | For | | For | |
| 1I. | | Election of Director for a term of one year: David Shedlarz | | Management | | For | | For | |
| 1J. | | Election of Director for a term of one year: Mark Douglas Smith, MD | | Management | | For | | For | |
| 1K. | | Election of Director for a term of one year: David B. Snow, Jr. | | Management | | For | | For | |
| 2. | | Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. | | Management | | For | | For | |
| 3. | | Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
TELEFLEX INCORPORATED
| Security | 879369106 | Meeting Type | Annual |
| Ticker Symbol | TFX | Meeting Date | 30-Apr-2021 |
| Record Date | 05-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Candace H. Duncan | | Management | | For | | For | |
| 1B. | | Election of Director: Stephen K. Klasko, M.D. | | Management | | For | | For | |
| 1C. | | Election of Director: Stuart A. Randle | | Management | | For | | For | |
| 2. | | Approval, on an advisory basis, of named executive officer compensation. | | Management | | For | | For | |
| 3. | | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2021. | | Management | | For | | For | |
| 4. | | Stockholder proposal, if properly presented at the Annual Meeting, to declassify our Board of Directors. | | Shareholder | | For | | | |
TERUMO CORPORATION
| Security | J83173104 | Meeting Type | Annual General Meeting |
| Ticker Symbol | N/A | Meeting Date | 22-Jun-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| | Please reference meeting materials. | | Non-Voting | | | | | |
| 1 | | Approve Appropriation of Surplus | | Management | | For | | For | |
| 2.1 | | Appoint a Director who is not Audit and Supervisory Committee Member Mimura, Takayoshi | | Management | | For | | For | |
| 2.2 | | Appoint a Director who is not Audit and Supervisory Committee Member Sato, Shinjiro | | Management | | For | | For | |
| 2.3 | | Appoint a Director who is not Audit and Supervisory Committee Member Takagi, Toshiaki | | Management | | For | | For | |
| 2.4 | | Appoint a Director who is not Audit and Supervisory Committee Member Hatano, Shoji | | Management | | For | | For | |
| 2.5 | | Appoint a Director who is not Audit and Supervisory Committee Member Nishikawa, Kyo | | Management | | For | | For | |
| 2.6 | | Appoint a Director who is not Audit and Supervisory Committee Member Kuroda, Yukiko | | Management | | For | | For | |
| 2.7 | | Appoint a Director who is not Audit and Supervisory Committee Member Nishi, Hidenori | | Management | | For | | For | |
| 2.8 | | Appoint a Director who is not Audit and Supervisory Committee Member Ozawa, Keiya | | Management | | For | | For | |
| 3.1 | | Appoint a Director who is Audit and Supervisory Committee Member Shibazaki, Takanori | | Management | | For | | For | |
| 3.2 | | Appoint a Director who is Audit and Supervisory Committee Member Nakamura, Masaichi | | Management | | For | | For | |
| 3.3 | | Appoint a Director who is Audit and Supervisory Committee Member Uno, Soichiro | | Management | | For | | For | |
| 4 | | Appoint a Substitute Director who is Audit and Supervisory Committee Member Sakaguchi, Koichi | | Management | | For | | For | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
| Security | 881624209 | Meeting Type | Annual |
| Ticker Symbol | TEVA | Meeting Date | 14-Jun-2021 |
| Record Date | 14-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Rosemary A. Crane | | Management | | For | | For | |
| 1B. | | Election of Director: Abbas Hussain | | Management | | For | | For | |
| 1C. | | Election of Director: Gerald M. Lieberman | | Management | | For | | For | |
| 1D. | | Election of Director: Prof. Ronit Satchi-Fainaro | | Management | | For | | For | |
| 2. | | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | | Management | | For | | For | |
| 3. | | To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2022 annual meeting of shareholders. | | Management | | For | | For | |
THERMO FISHER SCIENTIFIC INC.
| Security | 883556102 | Meeting Type | Annual |
| Ticker Symbol | TMO | Meeting Date | 19-May-2021 |
| Record Date | 26-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Marc N. Casper | | Management | | For | | For | |
| 1B. | | Election of Director: Nelson J. Chai | | Management | | For | | For | |
| 1C. | | Election of Director: C. Martin Harris | | Management | | For | | For | |
| 1D. | | Election of Director: Tyler Jacks | | Management | | For | | For | |
| 1E. | | Election of Director: R. Alexandra Keith | | Management | | For | | For | |
| 1F. | | Election of Director: Thomas J. Lynch | | Management | | For | | For | |
| 1G. | | Election of Director: Jim P. Manzi | | Management | | For | | For | |
| 1H. | | Election of Director: James C. Mullen | | Management | | For | | For | |
| 1I. | | Election of Director: Lars R. Sørensen | | Management | | For | | For | |
| 1J. | | Election of Director: Debora L. Spar | | Management | | For | | For | |
| 1K. | | Election of Director: Scott M. Sperling | | Management | | For | | For | |
| 1L. | | Election of Director: Dion J. Weisler | | Management | | For | | For | |
| 2. | | An advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
| 3. | | Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2021. | | Management | | For | | For | |
| 4. | | A shareholder Proposal regarding special Shareholder Meetings. | | Shareholder | | Against | | For | |
UNIQURE N.V.
| Security | N90064101 | Meeting Type | Annual |
| Ticker Symbol | QURE | Meeting Date | 16-Jun-2021 |
| Record Date | 19-May-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | Resolution to adopt the 2020 Dutch statutory annual accounts and treatment of the results. | | Management | | For | | For | |
| 2. | | Resolution to discharge liability of the members of the Board for their management. | | Management | | For | | For | |
| 3. | | Reappointment of David Meek as non-executive director. | | Management | | For | | For | |
| 4. | | Reappointment of Paula Soteropoulos as non-executive director. | | Management | | For | | For | |
| 5. | | Approval of the Amendment to the 2014 Restated Plan. | | Management | | For | | For | |
| 6. | | Resolution to reauthorize the Board to issue ordinary shares and options. | | Management | | For | | For | |
| 7. | | Resolution to reauthorize the Board to exclude or limit preemptive rights upon the issuance of ordinary shares. | | Management | | For | | For | |
| 8. | | Authorization of the Board to repurchase ordinary shares. | | Management | | For | | For | |
| 9. | | Resolution to appoint KPMG as external auditor of the Company for the 2021 financial year. | | Management | | For | | For | |
| 10. | | Approval of the Amendment to the Articles of Incorporation. | | Management | | For | | For | |
| 11. | | To approve, on an advisory basis, the compensation of the named executive officers of the Company. | | Management | | For | | For | |
UNITEDHEALTH GROUP INCORPORATED
| Security | 91324P102 | Meeting Type | Annual |
| Ticker Symbol | UNH | Meeting Date | 07-Jun-2021 |
| Record Date | 09-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Richard T. Burke | | Management | | For | | For | |
| 1B. | | Election of Director: Timothy P. Flynn | | Management | | For | | For | |
| 1C. | | Election of Director: Stephen J. Hemsley | | Management | | For | | For | |
| 1D. | | Election of Director: Michele J. Hooper | | Management | | For | | For | |
| 1E. | | Election of Director: F. William McNabb III | | Management | | For | | For | |
| 1F. | | Election of Director: Valerie C. Montgomery Rice, M.D. | | Management | | For | | For | |
| 1G. | | Election of Director: John H. Noseworthy, M.D. | | Management | | For | | For | |
| 1H. | | Election of Director: Gail R. Wilensky, Ph.D. | | Management | | For | | For | |
| 1I. | | Election of Director: Andrew Witty | | Management | | For | | For | |
| 2. | | Advisory approval of the Company's executive compensation. | | Management | | For | | For | |
| 3. | | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2021. | | Management | | For | | For | |
| 4. | | Approval of an amendment to the UnitedHealth Group 1993 Employee Stock Purchase Plan. | | Management | | For | | For | |
| 5. | | If properly presented at the 2021 Annual Meeting of Shareholders, the shareholder proposal set forth in the proxy statement requesting a reduction of the share ownership threshold for calling a special meeting of shareholders. | | Shareholder | | Against | | For | |
UNIVERSAL HEALTH REALTY INCOME TRUST
| Security | 91359E105 | Meeting Type | Annual |
| Ticker Symbol | UHT | Meeting Date | 02-Jun-2021 |
| Record Date | 08-Apr-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | DIRECTOR | | Management | | | | | |
| | | 1 | Marc D. Miller | | | | For | | For | |
| | | 2 | Gayle L. Capozzalo | | | | For | | For | |
| 2. | | Advisory (nonbinding) vote to approve named executive officer compensation. | | Management | | For | | For | |
| 3. | | To ratify the selection of KPMG, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
UNIVERSAL HEALTH SERVICES, INC.
| Security | 913903100 | Meeting Type | Annual |
| Ticker Symbol | UHS | Meeting Date | 19-May-2021 |
| Record Date | 25-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 2. | | Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
VENTAS, INC.
| Security | 92276F100 | Meeting Type | Annual |
| Ticker Symbol | VTR | Meeting Date | 25-May-2021 |
| Record Date | 31-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Melody C. Barnes | | Management | | For | | For | |
| 1B. | | Election of Director: Debra A. Cafaro | | Management | | For | | For | |
| 1C. | | Election of Director: Jay M. Gellert | | Management | | For | | For | |
| 1D. | | Election of Director: Matthew J. Lustig | | Management | | For | | For | |
| 1E. | | Election of Director: Roxanne M. Martino | | Management | | For | | For | |
| 1F. | | Election of Director: Marguerite M. Nader | | Management | | For | | For | |
| 1G. | | Election of Director: Sean P. Nolan | | Management | | For | | For | |
| 1H. | | Election of Director: Walter C. Rakowich | | Management | | For | | For | |
| 1I. | | Election of Director: Robert D. Reed | | Management | | For | | For | |
| 1J. | | Election of Director: James D. Shelton | | Management | | For | | For | |
| 1K. | | Election of Director: Maurice S. Smith | | Management | | For | | For | |
| 2. | | Approval, on an advisory basis, of the compensation of our named executive officers. | | Management | | For | | For | |
| 3. | | Ratification of the selection of KPMG LLP as our independent registered public accounting firm for fiscal year 2021. | | Management | | For | | For | |
VERONA PHARMA PLC
| Security | 925050106 | Meeting Type | Special |
| Ticker Symbol | VRNA | Meeting Date | 18-Dec-2020 |
| Record Date | 06-Nov-2020 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | To adopt new Articles of Association | | Management | | For | | For | |
VERONA PHARMA PLC
| Security | 925050106 | Meeting Type | Annual |
| Ticker Symbol | VRNA | Meeting Date | 27-Apr-2021 |
| Record Date | 12-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1. | | To re-elect Dr. David Ebsworth as a director of the Company. | | Management | | For | | For | |
| 2. | | To re-elect Dr. Martin Edwards as a director of the Company. | | Management | | For | | For | |
| 3. | | To re-elect Dr. Sven Anders Ullman as a director of the Company. | | Management | | For | | For | |
| 4. | | To re-elect Lisa Deschamps as a director of the Company. | | Management | | For | | For | |
| 5. | | To receive and adopt the U.K. statutory annual accounts and Directors' report for the year ended 31 December 2020. | | Management | | For | | For | |
| 6. | | To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors' Remuneration Report for the year ended 31 December 2020. | | Management | | For | | For | |
| 7. | | To receive and approve the U.K. Directors' Remuneration Policy. | | Management | | For | | For | |
| 8. | | To appoint PricewaterhouseCoopers LLP as the Company's auditors, to hold office until the conclusion of the next annual general meeting of shareholders. | | Management | | For | | For | |
| 9. | | To authorize the Audit and Risk Committee to determine the auditor's remuneration for the year ending December 31, 2021. | | Management | | For | | For | |
| 10. | | To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of GBP24,415,222.30. | | Management | | For | | For | |
| 11. | | To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561(1) of the Companies Act does not apply to any such allotment. | | Management | | For | | For | |
VERTEX PHARMACEUTICALS INCORPORATED
| Security | 92532F100 | Meeting Type | Annual |
| Ticker Symbol | VRTX | Meeting Date | 19-May-2021 |
| Record Date | 25-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Sangeeta Bhatia | | Management | | For | | For | |
| 1B. | | Election of Director: Lloyd Carney | | Management | | For | | For | |
| 1C. | | Election of Director: Alan Garber | | Management | | For | | For | |
| 1D. | | Election of Director: Terrence Kearney | | Management | | For | | For | |
| 1E. | | Election of Director: Reshma Kewalramani | | Management | | For | | For | |
| 1F. | | Election of Director: Yuchun Lee | | Management | | For | | For | |
| 1G. | | Election of Director: Jeffrey Leiden | | Management | | For | | For | |
| 1H. | | Election of Director: Margaret McGlynn | | Management | | For | | For | |
| 1I. | | Election of Director: Diana McKenzie | | Management | | For | | For | |
| 1J. | | Election of Director: Bruce Sachs | | Management | | For | | For | |
| 2. | | Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
| 4. | | Shareholder proposal, if properly presented at the meeting, regarding a report on lobbying activities. | | Shareholder | | Against | | For | |
| 5. | | Shareholder proposal, if properly presented at the meeting, regarding a report on political spending. | | Shareholder | | Against | | For | |
WATERS CORPORATION
| Security | 941848103 | Meeting Type | Annual |
| Ticker Symbol | WAT | Meeting Date | 11-May-2021 |
| Record Date | 17-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1.1 | | Election of Director to serve for a term of one year: Udit Batra | | Management | | For | | For | |
| 1.2 | | Election of Director to serve for a term of one year: Linda Baddour | | Management | | For | | For | |
| 1.3 | | Election of Director to serve for a term of one year: Michael J. Berendt | | Management | | For | | For | |
| 1.4 | | Election of Director to serve for a term of one year: Edward Conard | | Management | | For | | For | |
| 1.5 | | Election of Director to serve for a term of one year: Gary E. Hendrickson | | Management | | For | | For | |
| 1.6 | | Election of Director to serve for a term of one year: Pearl S. Huang | | Management | | For | | For | |
| 1.7 | | Election of Director to serve for a term of one year: Christopher A. Kuebler | | Management | | For | | For | |
| 1.8 | | Election of Director to serve for a term of one year: Flemming Ornskov | | Management | | For | | For | |
| 1.9 | | Election of Director to serve for a term of one year: Thomas P. Salice | | Management | | For | | For | |
| 2. | | To ratify the selection of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2021. | | Management | | For | | For | |
| 3. | | To approve, by non-binding vote, named executive officer compensation. | | Management | | For | | For | |
WELLTOWER INC.
| Security | 95040Q104 | Meeting Type | Annual |
| Ticker Symbol | WELL | Meeting Date | 26-May-2021 |
| Record Date | 30-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Kenneth J. Bacon | | Management | | For | | For | |
| 1B. | | Election of Director: Karen B. DeSalvo | | Management | | For | | For | |
| 1C. | | Election of Director: Jeffrey H. Donahue | | Management | | For | | For | |
| 1D. | | Election of Director: Philip L. Hawkins | | Management | | For | | For | |
| 1E. | | Election of Director: Dennis G. Lopez | | Management | | For | | For | |
| 1F. | | Election of Director: Shankh Mitra | | Management | | For | | For | |
| 1G. | | Election of Director: Ade J. Patton | | Management | | For | | For | |
| 1H. | | Election of Director: Diana W. Reid | | Management | | For | | For | |
| 1I. | | Election of Director: Sergio D. Rivera | | Management | | For | | For | |
| 1J. | | Election of Director: Johnese M. Spisso | | Management | | For | | For | |
| 1K. | | Election of Director: Kathryn M. Sullivan | | Management | | For | | For | |
| 2. | | The ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year 2021. | | Management | | For | | For | |
| 3. | | The approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the 2021 Proxy Statement. | | Management | | For | | For | |
ZIMMER BIOMET HOLDINGS, INC.
| Security | 98956P102 | Meeting Type | Annual |
| Ticker Symbol | ZBH | Meeting Date | 14-May-2021 |
| Record Date | 15-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Christopher B. Begley | | Management | | For | | For | |
| 1B. | | Election of Director: Betsy J. Bernard | | Management | | For | | For | |
| 1C. | | Election of Director: Michael J. Farrell | | Management | | For | | For | |
| 1D. | | Election of Director: Robert A. Hagemann | | Management | | For | | For | |
| 1E. | | Election of Director: Bryan C. Hanson | | Management | | For | | For | |
| 1F. | | Election of Director: Arthur J. Higgins | | Management | | For | | For | |
| 1G. | | Election of Director: Maria Teresa Hilado | | Management | | For | | For | |
| 1H. | | Election of Director: Syed Jafry | | Management | | For | | For | |
| 1I. | | Election of Director: Sreelakshmi Kolli | | Management | | For | | For | |
| 1J. | | Election of Director: Michael W. Michelson | | Management | | For | | For | |
| 2. | | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2021. | | Management | | For | | For | |
| 3. | | Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). | | Management | | For | | For | |
| 4. | | Approve the amended 2009 Stock Incentive Plan. | | Management | | For | | For | |
| 5. | | Approve the amended Stock Plan for Non-Employee Directors. | | Management | | For | | For | |
| 6. | | Approve the amended Deferred Compensation Plan for Non-Employee Directors. | | Management | | For | | For | |
| 7. | | Approve amendments to our Restated Certificate of Incorporation to permit shareholders to call a special meeting. | | Management | | For | | For | |
ZOETIS INC.
| Security | 98978V103 | Meeting Type | Annual |
| Ticker Symbol | ZTS | Meeting Date | 20-May-2021 |
| Record Date | 26-Mar-2021 | | |
| Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
| 1A. | | Election of Director: Sanjay Khosla | | Management | | For | | For | |
| 1B. | | Election of Director: Antoinette R. Leatherberry | | Management | | For | | For | |
| 1C. | | Election of Director: Willie M. Reed | | Management | | For | | For | |
| 1D. | | Election of Director: Linda Rhodes | | Management | | For | | For | |
| 2. | | Advisory vote to approve our executive compensation (Say on Pay). | | Management | | For | | For | |
| 3. | | Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2021. | | Management | | For | | For | |
| 4. | | Shareholder proposal regarding simple majority vote. | | Shareholder | | Against | | For | |
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| (Registrant) | Tekla World Healthcare Fund | |
| | | |
| By (Signature and Title)* | | |
| | | |
| | /s/ Daniel R. Omstead | |
| | (Daniel R. Omstead, President) | |
| | | |
| Date | 8/19/21 | |
| | | | | |
*Print the name and title of each signing officer under his or her signature.
